Top Stories

Colorado BioScience Association Appoints Leaders from Amgen and Validus Cellular Therapeutics to Lead Board of Directors

Executives from JP Morgan Chase & Company, AGC Biologics, Innosphere Ventures, GelSana, and Teru...

Learn More

Fitzsimons Innovation Community Companies Demonstrate Momentum

Fitzsimons Innovation Community has been a partner of the Rocky Mountain Life Sciences Investor...

Learn More

Weekly Update: Biden Administration Cancer Moonshot Initiative; Bi-Partisan Majority Support in Congress - Multi-Cancer Early Detection Screening Coverage Act (S.1873/ H.R. 1946)

President Biden’s Cancer Moonshot Initiative On the 60th anniversary of President Kennedy’s “We Choo...

Learn More

Get weekly updates from Colorado’s leading source
for life sciences news and information.

Join Mailing List
Media Resources

Fitzsimons Innovation Community Companies Demonstrate Momentum

Fitzsimons Innovation Community has been a partner of the Rocky Mountain Life Sciences Investor & Partnering Conference since its inception, recognizing the importance of this gathering to showcas...

Learn More

Weekly Update: Biden Administration Cancer Moonshot Initiative; Bi-Partisan Majority Support in Congress - Multi-Cancer Early Detection Screening Coverage Act (S.1873/ H.R. 1946)

President Biden’s Cancer Moonshot Initiative On the 60th anniversary of President Kennedy’s “We Choose to Go to the Moon” speech, President Biden gave an update on his Cancer Moonshot Initiative, whic...

Learn More

CBSA Remains Active on the Critical Need to Reauthorize Vital SBIR/STTR Programs for Life Sciences

Act Today and Tell Your Member of Congress to Support Vital SBIR/STTR Programs for Life Sciences The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs ar...

Learn More

Weekly Policy Blog: Colorado BioScience Political Action Committee Fuels Policy + Advocacy Engagement and Impact

The Colorado BioScience Political Action Committee (CBSA PAC), a bipartisan state political action committee, provides opportunities to educate candidates for the state legislature about our life scie...

Learn More

Colorado BioScience Association Announces Record-Breaking Attendance at Vail Investor Conference

Rocky Mountain Life Sciences Investor & Partnering Conference to Welcome More than 200 Attendees Denver – Colorado BioScience Association (CBSA) will highlight the future of health innovation at t...

Learn More

Weekly Policy Blog: August Prescription Drug Affordability Review Board (PDAB) Meeting

On August 26, CBSA and our partners participated in the state Prescription Drug Affordability Review Board (PDAB) meeting, which was open to the public. The PDAB was created in 2021 when the state leg...

Learn More

InVitria’s Technology Eliminates Risks and Protects Patients

InVitria was founded with a mission to eliminate the need for blood-derived raw materials in biomanufacturing and drug formulation, primarily targeting the growing demand for human and animal serum in...

Learn More

Weekly Policy Blog: Ethylene Oxide – Critical in Protecting Patient Health

Ethylene Oxide (EtO or EO) is a colorless gas used commercially in a wide variety of ways, including the production of textiles, personal care items, and the sterilization of medical devices, cosmetic...

Learn More

Colorado BioScience Association Appoints Emily Martini as Vice President, Partnerships

Martini to Lead Strategic Partnerships, Initiatives, and Programs in Newly Created Role Denver – Colorado BioScience Association (CBSA) announces the appointment of Emily Martini as Vice President of...

Learn More

Weekly Policy Blog: President Biden Signs Inflation Reduction Act into Law

On August 16, 2022, President Biden signed the Inflation Reduction Act, a bill aimed at addressing high inflationary costs. The massive bill increases corporate taxes and includes measures designed to...

Learn More

Weekly Policy Blog: Deadline Approaches to Reauthorize User Fee Agreements

CBSA and our national partners support the renewal of the critically important User Fee Agreements, including the Pharmaceutical Drug User Fee Act (PDUFA) and the Medical Device User Fee Act (MDUFA)....

Learn More

CBSA Remains Active on Critical Federal Legislation

Act Today and Tell Your Member of Congress: Oppose Government Price Setting Congress is negotiating sweeping legislation that impacts life sciences. The current reconciliation bill includes language t...

Learn More

Weekly Policy Blog: CBSA’s Continued Advocacy on Important Federal Policy Initiatives

Congress is negotiating sweeping legislation that impacts life sciences. Colorado BioScience Association (CBSA) remains active on these important legislative proposals, which include supporting the re...

Learn More

Fitzsimons Innovation Community Invests to Meet Market Needs

Fitzsimons Innovation Community has maintained a fast pace of development over the past 10 years, building capacity to meet market needs. With an increase in the demand for move-in ready life sciences...

Learn More

Weekly Policy Update: SBIR/STTR Critical to Life Sciences – Support Our Work on Reauthorization

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs are vital for our life sciences community. They provide early non-dilutive funding to advance high-...

Learn More

Weekly Policy Update: Where We Stand Today on Reauthorization of SBIR/STTR

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs are vital for our life sciences community. They provide early non-dilutive funding to help advance...

Learn More

Weekly Policy Update: CBSA Urges Repeal of Harmful R&D Amortization Provision

Earlier this month, Colorado BioScience Association (CBSA) partnered with Biotechnology Innovation Organization (BIO) and sent a letter to Congress urging immediate legislative action to repeal the ha...

Learn More

Invenux Accelerates Solutions for the Future of Rare Disease Patients

Invenux, LLC, a privately held clinical stage biopharmaceutical company, is propelling its research and clinical trials forward to treat sickle cell disease in the U.S. and worldwide. By developing a...

Learn More

Manager’s Amendment in FDA Safety and Landmark Advancements (FDASLA) Act Would Include and Allow Drug Importation

Earlier this month, Colorado BioScience Association (CBSA) engaged on the U.S. Food and Drug Administration’s (FDA) Safety and Landmark Advancements (FDASLA) Act. CBSA and our national partners suppor...

Learn More

Weekly Policy Update: CBSA Engages on FDA Safety and Landmark Advancements (FDASLA) Act

Colorado BioScience Association (CBSA) and our national partners support the critically important reauthorization of the U.S. Food and Drug Administration’s (FDA) prescription drug, generic drug, bios...

Learn More

Colorado Governor Jared Polis Signs Reauthorization and Expansion of Advanced Industries Tax Credit Into Law

Colorado BioScience Association thanks Governor Jared Polis for signing the Advanced Industries Tax Credit, House Bill 1149, into law. “This legislation supports the incredible breakthroughs driving C...

Learn More

Colorado BioScience Association Applauds the 2022 Class of Boettcher Investigators

Boettcher Foundation awards $1.88 million in biomedical research grant funding to Colorado researchers DENVER, June 1, 2022 — Colorado BioScience Association (CBSA) congratulates the 2022 class of Boe...

Learn More

Validus Cellular Therapeutics Gains Momentum in Cellular Therapy

Validus Cellular Therapeutics, Inc. is pioneering the use of cellular therapy for the treatment of drug-resistant, chronic bacterial infections. Cellular therapy approaches have been successful for on...

Learn More

Weekly Policy Update: Small Business Innovation Research and Small Business Technology Transfer Programs Update

A longstanding policy priority for CBSA is supporting our ecosystem’s need for increased access to capital. Through our Capital + Growth efforts, we work closely with public and private partners to ac...

Learn More

Historic $200 Million Commitment to the University of Colorado Anschutz Medical Campus Fuels Advancements in Treatments and Cures

The University of Colorado Anschutz Medical Campus today announced the creation of the Gates Institute, a state-of-the-art facility that will focus on rapidly translating laboratory findings...

Learn More

Innosphere Ventures, Colorado BioScience Association, and Colorado BioScience Institute Announce the Colorado Life Sciences Incubation Program 2022 Cohort

Early-Stage Companies in Biotech, Medical Device, Oral Health/Teledentistry, and Health Technology Selected to Take Part in Year-Long, State-Funded Program Denver and Fort Collins, Colo.- Innosphere V...

Learn More

CBSA Congratulates Advanced Industries Accelerator Grant Recipients

Colorado’s Office of Economic Development and International Trade (OEDIT) announced the newest recipients of state-funded Advanced Industries Accelerator Grants this week. Colorado BioScience Associat...

Learn More

Weekly Policy Update: Legislative Session Closes – CBSA Reviews Policy Accomplishments

The 2022 legislative session, the Second Regular Session of the 73rd General Assembly, has concluded. It was an unprecedented session that  began with the legislature having significant financial...

Learn More

State Tax Credit Expanded: A Win for Our Community

CBSA is pleased to share news of a significant win at the State Capitol for our life sciences community. Late last night, the legislature voted to reauthorize the Advanced Industries Tax Credit Progra...

Learn More

Weekly Policy Update: Legislative Session Enters the Final Weeks

The legislative session is scheduled to end on Wednesday, May 11th, or in about 12 days. As we enter the final stretch, the CBSA team continues to weigh in on key legislation and advocate on behalf of...

Learn More

Atara Biotherapeutics Fosters Hope for Those Impacted by Cancer, Autoimmune Diseases

Atara Biotherapeutics is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative off-the-shelf therapies for patients with serious diseases including solid tumor...

Learn More

What is Happening in Life Sciences Valuations?

Guest Post by Peter Adams, Executive Director, Rockies Venture Club Anyone who has been watching valuations in life sciences deals over the past couple of years knows that median valuations in life sc...

Learn More

Colorado BioScience Association Appoints Leaders from Amgen and Validus Cellular Therapeutics to Lead Board of Directors

Executives from JP Morgan Chase & Company, AGC Biologics, Innosphere Ventures, GelSana, and Terumo Blood and Cell Technologies Join Board Denver – Colorado BioScience Association (CBSA), which cre...

Learn More

Weekly Policy Update: Congressional Tax Package Could Support Further Industry Growth

CBSA is committed to keeping our community updated on issues that impact life sciences. Our Policy + Advocacy team is reviewing newly proposed legislation that could directly affect life sciences comp...

Learn More

Why Do So Many Angel/VC Investors Misunderstand Life Sciences Investing?

Guest Post by Peter Adams, Executive Director, Rockies Venture Club I am often surprised when I meet investors who claim that they invest in just about anything but life sciences.  Last year heal...

Learn More

Weekly Policy Update: Medical Device User Fee Amendments (MDUFA)

CBSA and our national partners support the renewal of the critically important Medical Device User Fee Amendments (MDUFA). After months of negotiations among the FDA and industry advocacy groups, incl...

Learn More

Weekly Policy Update: Small Business Innovation Research and Small Business Technology Transfer Programs

A longstanding policy priority for CBSA is supporting our ecosystem’s need for increased access to capital. Through our Capital + Growth efforts, we work closely with public and private partners to ac...

Learn More

Weekly Policy Update: TRIPS Waiver Update

Colorado BioScience Association continues to monitor the international debate on the Trade-Relations Aspects of Intellectual Property Rights (TRIPS) Waiver, due the harmful precedent the waiving of IP...

Learn More

CBSA Thanks AGC Biologics, Our Sustaining Sponsor

Thank you to CBSA Sustaining Sponsor, AGC Biologics! AGC Biologics deepened its investment in CBSA and Colorado’s life sciences ecosystem with our highest level of sponsorship. We are thrilled by the...

Learn More

Greffex Transforms Vaccine and Gene Therapy Work

Greffex™ is a privately held, multi-national company that developed a novel genetic platform for the development and production of vaccines. The GREVAX™ Universal Platform delivers vaccines in a faste...

Learn More

Weekly Policy Update: Advocacy on Congressional Tax and Investment Policies

Colorado BioScience Association is watching legislative proposals at the federal level that would be harmful to business. These proposals would have impacts on Qualified Small Business Stock and tax c...

Learn More

Weekly Policy Update: Accelerated Approvals Reform Bill Introduced

CBSA is committed to keeping our community updated on issues that impact life sciences. Our Policy + Advocacy team is reviewing newly proposed legislation that could directly affect life sciences comp...

Learn More

Support Needed: Colorado Coalition’s Application for the Build Back Better Grant

Colorado BioScience Association is asking for your support. The Colorado Coalition, which includes CBSA, is working to secure up to $100 million in funding for life sciences and cleantech in our state...

Learn More

Weekly Policy Update: President Biden Delivers First State of the Union Address

Earlier this week, President Biden delivered his first State of the Union address as President to a joint session of Congress. While the speech was primarily focused on the conflict in Ukraine, the Pr...

Learn More

Colorado Life Sciences Incubation Program: New Program for Colorado-Based Startups

Colorado BioScience Association is proud to launch a new incubation program for early-stage companies in partnership with Innosphere and our sister organization, Colorado BioScience Institute. The yea...

Learn More

LabXchange Provides Value: Colorado BioScience Institute and Amgen Foundation Support Teacher Trainings in Colorado

Through the generous support of the Amgen Foundation, the Colorado BioScience Institute collaborates with Harvard University’s LabXchange to provide teacher trainings in Colorado. LabXchange sat down...

Learn More

Weekly Policy Update: HB22-1149 Advanced Industries Investment Tax Credit Heads to First Committee

CBSA is proud to lead the advocacy efforts to reauthorize the Advanced Industries Investment Tax Credit this session through HB22-1149. The bill is sponsored by Rep. Shannon Bird, Rep. Mike Lynch, and...

Learn More

Colorado Research Partners Cultivates Future of Fructose Inhibitors

Colorado Research Partners is a pharmaceutical company in the Fitzsimons Innovation Community that brings enthusiasm to curbing the effects of nonalcoholic fatty liver disease using their fructose inh...

Learn More

Weekly Policy Update: Colorado BioScience Association’s Annual Day at the Capitol

During our annual Day at the Capitol event, members heard about CBSA's state advocacy efforts and the issues impacting Colorado's life sciences ecosystem this legislative session. Lieutenant Governor...

Learn More

Innosphere Ventures, Colorado BioScience Association, and Colorado BioScience Institute Announce New Incubation Program to Grow Life Sciences Startups

State Funding from Advanced Industries Business Accelerator Grant to Support Program DENVER, February 17, 2022 — Innosphere Ventures, Colorado BioScience Association (CBSA), and Colorado BioScience In...

Learn More

Weekly Policy Update: State Regulation of Ethylene Oxide

The regulatory environment regarding the usage of Ethylene Oxide (EtO) for the sterilization of medical devices is constantly evolving. Colorado state legislators are drafting a proposal that would cr...

Learn More

Weekly Policy Update: Biden Administration Relaunches “Cancer Moonshot”

Earlier this week, President Biden relaunched the Cancer Moonshot initiative which was originally created while he was serving as Vice President in 2016. And today also happens to be World Cancer Day...

Learn More

The Colorado BioScience Institute and St. Vrain Valley Schools Receive $435,200 Grant to Advance Workforce Pathways

FREDERICK, Colorado – The Colorado BioScience Institute and St. Vrain Valley Schools have been awarded a $435,200 Workforce Innovation Grant from the Weld County Workforce Development Board in su...

Learn More

Weekly Policy Update: State Opioid Fee

CBSA is tracking the development of a policy proposal from legislators that would mandate a fee on opioid manufacturers and distributors, along with manufacturers of other controlled substances includ...

Learn More

Fitzsimons Innovation Community Bioscience 5 Development Officially Underway

Fitzsimons Innovation Community is making progress on the buildout of their newest bioscience facility, for cell and gene therapy. With Fitzsimons Innovation Community and CU Anschutz Medical Campus i...

Learn More

Weekly Policy Update: Medicaid's 340B Program

As the General Assembly wraps up its second week back in session, the Colorado BioScience Association is tracking the development of a policy proposal from legislators that could have significant impa...

Learn More

Weekly Policy Update: Start of the Colorado Legislative Session

The Colorado State Legislature returned this past Wednesday to start the second regular session of the 73rd General Assembly. Even before the legislature’s return, Colorado BioScience Association has...

Learn More

Weekly Policy Update: December State Budget Forecast

In December, the Governor's Office of State Planning and Budgeting (OSPB), along with nonpartisan Legislative Council staff, presented strong budget forecasts which are a positive sign for the state’s...

Learn More

CBSA President and CEO Is Recognized in Colorado Inno as a Top Tech Hire 2021

CBSA President and CEO, Elyse Blazevich, has been recognized in Colorado Inno as a top tech hire. Elyse strategically advances CBSA’s work to build a pro-innovation environment for life sciences in Co...

Learn More

CBSA Champions Life Sciences in 2021 with End of Year Highlights

Colorado’s reputation as a leading location for health innovation continues to accelerate. In 2021, we broke the top 10 in a new ranking of top North American life sciences hubs, climbing to #8. We ac...

Learn More

Weekly Policy Update: Build Back Better Act Stalled in the Senate

Over the weekend Democratic Senator Joe Manchin of West Virginia announced that he would be voting ‘no’ on the Build Back Better Act (BBBA). His concerns with the legislation are primar...

Learn More

Weekly Policy Update: FDA Commissioner Nominee Confirmation Hearing

Last month, President Biden announced Robert Califf, M.D. as his nominee for Commissioner of the Food and Drug Administration (FDA). Dr. Califf’s confirmation hearing was held this week by the Senate...

Learn More

Colorado Life Sciences Companies Raise a Record $2.4 Billion in 2021

Major IPOs, Venture Capital Funding, and Government Funding Accelerate Health Innovation DENVER – Colorado’s life sciences ecosystem raised $2.4 billion in 2021, a new record for the fast-growing comm...

Learn More

Essent Biologics and Amnion Foundation Partner to Provide Germinal-Origin Cells to Further Drug Discovery and Regenerative Medicine Research

Distribution Agreement Will Allow Access to Innovative Full-Term Placenta-Derived Cells to Support Ground-Breaking Research Centennial, Colo. — December 14, 2021 — Essent Biologics™, a leading supplie...

Learn More

Weekly Policy Update: Business Implications from Pending Legislative & Regulatory Activities + CBSA USPTO Roundtable

In addition to the ongoing conversations in the Senate related to the House of Representatives’ version of the $1.75 trillion Build Back Better Act (BBBA), the federal government will be seeking stric...

Learn More

Weekly Policy Update: TRIPS Waiver for COVID-19 Vaccines and Treatments Remains Under Consideration by the World Trade Organization

CBSA continues to monitor the international debate on the Trade-Relations Aspects of Intellectual Property Rights (TRIPS) Waiver. Our monitoring of the waiver is due the harmful precedent waving of IP...

Learn More

Pathways Bioscience Seeks to Optimize Aging

Pathways Bioscience’s technology improves healthspan and overcomes health and wellness problems associated with aging. By use of a dietary supplement with naturally occurring plant-based ingredients,...

Learn More

Weekly Policy Update: World Antimicrobial Awareness Week + Cures 2.0 & PASTEUR Act

World Antimicrobial Awareness Week, hosted by the World Health Organization last week, focused on increasing awareness of global antimicrobial resistance (AMR). and encou...

Learn More

CBSA Applauds Advanced Industries Accelerator Grant Recipients

Colorado BioScience Association applauds CBSA members and honorees from across our state's innovation ecosystem who were awarded Advanced Industries Accelerator Grants by Colorado’s Office of Economic...

Learn More

Weekly Policy Update: Qualified Small Business Stock Implications within the Build Back Better Act

In addition to the price-setting policies and investment implications related to the capital gains tax rate and IRA provisions, the House version of the Build Back Better...

Learn More

Weekly Policy Update: CBSA Hosts Ecosystem Briefing and Roundtable Discussion with Belgian Ambassador Jean-Arthur Régibeau

This week, CBSA was honored to host a dynamic briefing and roundtable discussion for Belgian Ambassador Jean-Arthur Régibeau. Our community appreciated the opportunity to...

Learn More

Bond Pet Foods Develops The World's First Animal-Free Chicken Protein For Dog And Cat Nutrition

Proprietary approach brews chicken protein through biotechnology and fermentation, instead of harvesting conventionally on farm and field Bond Pet Foods, Inc., the Boulder-based company working with b...

Learn More

CBSA Website Wins National Award

The Colorado BioScience Association website recently received national recognition by the w3 Awards organization, which celebrates digital excellence. Our site was honored in the industry association...

Learn More

Weekly Policy Update: Agreement Reached on Drug Pricing Policies within the Budget Reconciliation Package

Late last week, the White House released a framework for the budget reconciliation package, known as the Build Back Better Act. The original package had a total cost of $3.5 trillion. The latest frame...

Learn More

Weekly Policy Update: New CBSA President & CEO Brings Direct Experience with State and Federal Policy Priorities

The CBSA Board of Directors announced the appointment of Elyse Blazevich as our President & CEO on October 27. The Association is fortunate to have som...

Learn More

Colorado BioScience Association Appoints Elyse Blazevich, Medical Device Company Founder and Business Leader, as President & CEO

Blazevich Steps into New Role During Period of Significant Momentum for Life Sciences in Colorado Denver – Colorado BioScience Association (CBSA) announces the appointment of medical device company fo...

Learn More

Weekly Policy Update: Medicare Coverage of Innovative Technology (MCIT) Pathway

The Advanced Medical Technology Association (AdvaMed) and the Medical Device Manufacturers Association (MDMA) submitted comments last week to the Centers for Medicare...

Learn More

ClearSight Seeks to Restore Vision and Improve the Quality of Life for Millions

ClearSight is developing innovative solutions for ophthalmologists that aim to change the standard of care for many patients. Utilizing a micropattern and patented design, the first intraocular lens C...

Learn More

Weekly Policy Update: Legislators of the Year Announced + TRIPS Waiver Update

Legislators of the Year  CBSA recognized four state legislators for their leadership on issues critical to life sciences, earlier this week at the Innovation Forward Forum + Awards Cele...

Learn More

Colorado BioScience Association Recognizes Legislators of the Year at Innovation Forward: Forum + Awards Celebration

Four State Legislators Honored for their Leadership on Issues Important to Life Sciences Denver – Colorado BioScience Association (CBSA) honored Colorado’s life sciences community at the  Innovat...

Learn More

Colorado BioScience Association Highlights Health Innovators at Innovation Forward: Forum + Awards Celebration

LightDeck Diagnostics Named Company of the Year, Artisan Bio Honored as Rising Star of the Year Denver – Colorado BioScience Association (CBSA) honored Colorado’s life sciences community at the ...

Learn More

Life Sciences Companies Pitch at Innovation Forward: Forum + Awards Celebration on October 12 for $7,500 Prize

Colorado BioScience Association is excited to welcome our life sciences ecosystem back to in-person education + networking. We’re planning the largest gathering of our community since early 2020. We a...

Learn More

Weekly Policy Update: Tax and Investment Implications within the Budget Reconciliation Package

In addition to the price-setting policies from H.R. 3, which are already included in House Democrats' version of the 10-year, $3.5 trillion spending plan, two tax policies along with ch...

Learn More

Zalgen Labs Develops and Deploys Solutions to Emerging Viral Threats

Zalgen Labs is making a difference for patients around the world with solutions to viral threats and neglected tropical diseases. They specialize in the design and production of superior biological mo...

Learn More

Weekly Policy Update: State Budget Forecast

The Governor's Office of State Planning and Budgeting (OSPB), along with nonpartisan Legislative Council staff, presented similar budget forecasts during their quarterly presentations to the...

Learn More

Weekly Policy Update: Congressional Drug Pricing Effort Advances

House Democrats are in the process of including the policies contained within H.R. 3 into their 10-year, $3.5 trillion spending plan that they hope to pass using the budget reconciliation process.  Cu...

Learn More

Colorado BioScience Association to Celebrate Leading Life Sciences Companies at Awards Celebration

LightDeck Diagnostics, Proov, and OnKure Named as Company of the Year Finalists; Artisan Bio, Enveda Biosciences, and Foresight Diagnostics Named Rising Star of the Year Finalists Denver – Colorado Bi...

Learn More

Weekly Policy Update: Biden Administration Releases Drug Pricing Plan

The Biden Administration through the Department of Health and Human Services (HHS) published a white paper detailing multiple policy strategies to address prescription drug costs, the paper is in resp...

Learn More

Weekly Policy Update: New Survey Provides Limited Insight into Coloradans' views on Healthcare

Consumers for Quality Care (CQC) who state they are a coalition of advocates and former policymakers working to provide a voice for patients in the health care debate as they demand better care, relea...

Learn More

GelSana Therapeutics Provides Breakthrough in Hydrogel Technology

GelSana Therapeutics, Inc. is fabricating next-generation wound healing hydrogels that offer faster healing with less inflammation, especially for chronic wounds such as diabetic ulcers. The GelSana t...

Learn More

Weekly Policy Update: Congressional Drug Pricing Efforts + CBSA Medical Device Symposium

H.R. 3 Impact House Speaker Nancy Pelosi originally released H.R 3, the Lower Drug Costs Now Act in 2019, the Act went on to pass out of the chamber by a slim bipartisan margin where it then faced pre...

Learn More

Colorado BioScience Association Announces Appointment of Vice President

Michael Crews to Advocate for Life Sciences Priorities at the State and Federal Level DENVER – Colorado BioScience Association (CBSA) today announced a key hire, new Vice President Michael Crews. Crew...

Learn More

Weekly Policy Update: TRIPS Waiver for COVID-19 Vaccines and Treatments still under consideration by the World Trade Organization

Earlier this year the Colorado BioScience Association (CBSA) along with 300 other global biotechnology companies and associations signed onto a declaration outlining the harm of a proposed waiver of t...

Learn More

Weekly Policy Update: CBSA Applauds Senator Bennet’s Leadership on Early Cancer Detection Legislation

Last week, Colorado U.S. Senator Michael Bennet hosted a roundtable discussion on his Medicare Multi-Cancer Early Detection Screening Coverage Act. Kathleen (Kiki) Traylor, M.D., State Affairs Directo...

Learn More

CBSA Applauds Rep. Jason Crow for Supporting Health Innovation in Our State

Colorado BioScience Association (CBSA) applauds Representative Jason Crow (D-CO) for re-introducing the Small Business Innovation Voucher Act with Representative Tim Burchett (R-TN). This bipartisan l...

Learn More

CBSA Presents on Thriving Life Sciences Community to ACE Delegation

Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. Last week, CBSA’s President and CEO Jennifer Jones Paton presented at a session of The ACE 13 ev...

Learn More

Event Series The Leader Within Highlights Inspiring Stories of Leadership

In 2021, Colorado Bioscience Association and the Medtronic Women’s Network teamed up to create The Leader Within – a virtual event series to hear from local life sciences leaders in an exclusive setti...

Learn More

Weekly Policy Update: CBSA Lays Groundwork for Upcoming 2022 Session

Colorado BioScience Association (CBSA) leads Policy + Advocacy efforts to support a collaborative, pro-innovation environment for life sciences in Colorado. We work to advance state and federal polici...

Learn More

A Message from President & CEO Jennifer Jones Paton on her Transition from CBSA

Dear Colorado Life Sciences Community, After almost five years at Colorado BioScience Association and more than two years as President & CEO, I have decided to transition from my role at CBSA to f...

Learn More

Colorado BioScience Association Announces Departure of President & CEO, Jennifer Jones Paton

Board of Directors to Begin Comprehensive Search for Replacement DENVER – Colorado BioScience Association (CBSA) announced Jennifer Jones Paton’s plans to transition from her President & CEO role....

Learn More

Policy + Advocacy: End-of-Session Report

CBSA leads Policy + Advocacy efforts to support a collaborative, pro-innovation environment for life sciences in Colorado. We work to advance state and federal policies that support the companies in o...

Learn More

A Letter from Our President & CEO

Colorado Life Sciences Community: Our ecosystem continues to demonstrate remarkable growth and innovation as we enter the second half of 2021. Medtronic broke ground on a new campus in Lafayette at th...

Learn More

Foresight Diagnostics Transforms Standard of Care for Disease Surveillance

Foresight Diagnostics, an emerging leader in blood-based lymphoma disease monitoring, is transforming patient care with groundbreaking cancer surveillance technology. The Foresight team can identify p...

Learn More

Weekly Policy Update: CBSA Signs BIO CEO Declaration on Global Access to COVID-19 Vaccines and Treatments and the Role of Intellectual Property

Colorado BioScience Association (CBSA) and close to 300 other global biotechnology companies and associations have come together in opposition to waiving IP protections for COVID-19 vaccines and treat...

Learn More

Weekly Policy Update: PASTEUR Act, COVID-19 Intellectual Property, and June Economic Forecast

CBSA Applauds Senator Bennet for Legislation to Ensure Patient Access to Leading-Edge Diagnostics Last week Senator Michael Bennet introduced new bipartisan legislation in the U.S. Senate that would s...

Learn More

A Letter from CBSA President & CEO Jennifer Jones Paton: 2021 Legislative Session

Dear Colorado Life Sciences Community, Colorado BioScience Association builds a collaborative, pro-innovation environment for life sciences innovation. Through our Policy + Advocacy efforts, we work a...

Learn More

Legislative Session Closes – CBSA Reviews Policy Accomplishments

The 2021 legislative session, the First Regular Session of the 73rd General Assembly, has concluded. It was an unprecedented session that started during the heights of the COVID-19 pandemic and ended...

Learn More

Join Our Team at Colorado BioScience Association

It’s an incredible time to champion life sciences. Big thinkers and bold leaders from Colorado are saving and changing lives around the world with health innovations, products, and solutions. Our comm...

Learn More

Policy Wins for Colorado Life Sciences Community with SB 175 Amendments

As the legislative session nears an end, health care and prescription drug bills are still being negotiated. Last week, Colorado SB 175 passed the House floor on a second reading on Friday. CBSA thank...

Learn More

Weekly Policy Update: Two State Bills Move Forward That Could Adversely Impact Life Sciences Ecosystem

The end of the 2021 Colorado legislative session is quickly approaching. The last possible day (June 12) is less than two weeks away and it’s possible that the General Assembly could even wrap up befo...

Learn More

Colorado BioScience Association Celebrates the 2021 Class of Boettcher Investigators

Boettcher Foundation awards $1.41 million in biomedical research grant funding to Colorado researchers Colorado BioScience Association (CBSA) congratulates six leading Coloradoresearchers who are the...

Learn More

Exxel Pharma: Small Molecule Therapy, Big Impact

Exxel Pharma is a development stage company that combines world-class leadership, expert technological know-how and experience from the pharmaceutical industry to develop medicines for significant unm...

Learn More

Weekly Policy Update: State Bills Advance to Create More Small Business Support Programs

Two state bills advanced this week that would create new programs to support Colorado small businesses. These proposals are part of a larger $800 million state stimulus package that targets aide to ce...

Learn More

CBSA Congratulates Advanced Industries Accelerator Grant Recipients

Colorado BioScience Association congratulates CBSA members awarded proof-of-concept and early-stage capital grants by Colorado’s Office of Economic Development and International Trade (OEDIT). A total...

Learn More

Weekly Policy Update: CBSA Hosts Congressional Briefing on the Impacts of Reference Pricing

CBSA partnered with We Work for Health Colorado this week to host a briefing for Colorado congressional offices about the impacts of international reference pricing on our innovation ecosystem. Duane...

Learn More

CBSA Congratulates Emily Roberts on New Role, Launches Search for Replacement CBSA

Emily Roberts has accepted a position at CBSA member company Genentech on the issue advocacy team. CBSA congratulates Emily on this exciting next step in her career.  She has made a sig...

Learn More

Weekly Policy Update: Drug Review Board Legislation Passes State Senate

Senate Bill 175 (Prescription Drug Affordability Review Board) passed the Colorado Senate today on a vote of 19-16. The bill would create a prescription drug review board in Colorado that is charged w...

Learn More

Weekly Policy Update: Colorado Legislature Finalizes State Budget

The Colorado legislature finalized the state budget today, which will now be sent to Governor Polis for his signature. In addition to funding day-to-day operations of the state government, the $34.6 b...

Learn More

CPC Works to Propel Beyond Research, Engage Community Directly

CPC is a non-profit, mission-driven Academic Research Organization (ARO) that supports all phases of clinical research. Their academically led team provides fullservice support, offering scientific ov...

Learn More

Colorado BioScience Association Appoints New Board Members

Colorado BioScience Association (CBSA) today announced the appointment of seven new members to its board of directors, Jim Kasic, CEO of EndoShape and Chairman of Boulder IQ; Anil Mathai, Vice Preside...

Learn More

Colorado’s Life Sciences Ecosystem Achieves Record Q1 Fundraising

Colorado BioScience Association (CBSA) today announced the state’s life sciences community raised an unprecedented $704 million in the first quarter of 2021. Capital from public, private, and federal...

Learn More

CBSA Urges CMS to Implement MCIT Rule Without Delay

In January, CMS finalized a new rule called Medicare Coverage of Innovative Technologies (MCIT). The rule provides immediate national Medicare coverage for FDA-designated breakthrough devices and diag...

Learn More

Weekly Policy Update: Biden’s Spending Proposal Signals Key Healthcare Priorities

Last week the White House unveiled a $1.5 trillion discretionary spending request for the coming fiscal year. The request, which is only part of the President’s full budget proposal, is a sharp depart...

Learn More

Your Help Needed Now: Tell Colorado Legislators to Protect Life Sciences Innovation

The Colorado state legislature is considering a bill that creates a state drug review board with the power to set payment rates for medicines in Colorado. The unelected board could set price limits wi...

Learn More

Weekly Policy Update: CBSA Convenes Roundtable Discussion with Congressman Joe Neguse

CBSA convened a virtual roundtable this week with Congressman Joe Neguse, who represents Colorado’s second Congressional district. It was a great opportunity for leaders in our ecosystem to highlight...

Learn More

Weekly Policy Update: New Study Examines Impact of Federal Drug Pricing Proposal

Last week, the Council of State Bioscience Associations released a new study that shows the impact of foreign reference pricing on patient access to lifesaving medicines and investment in new treatmen...

Learn More

PhosphoSolutions Drives Scientific Breakthroughs with Research Antibodies

PhosphoSolutions specializes in producing high-quality research antibodies for the neuroscience community. The company's research antibodies provide critical information on drug effectiveness that dri...

Learn More

Weekly Policy Update: State Leaders Solicit Input on Colorado’s Stimulus Funding

Colorado and local governments are expected to receive billions of dollars from the 2021 American Rescue Plan. In an effort to better understand the needs and current economic challenges facing the st...

Learn More

Novartis Gene Therapies News

Work in Progress to Support Jobseekers and Identify New Candidates for Facility Novartis Gene Therapies, formerly AveXis, plans to wind down its Longmont facility in July. Novartis Gene Therapies has...

Learn More

Robust Speaker Line-Up and Pitch Event Winner at CBSA-Amgen Healthcare Innovation

The CBSA-Amgen Healthcare Innovation Event took place this week filled with engaging speakers and a robust audience. Thank you to our sponsors Amgen, Amgen Ventures and CBSA sustaining spons...

Learn More

Weekly Policy Update: CBSA Testifies on Local Impact of Drug Pricing Bill

This week CBSA testified in opposition to Senate Bill 175 in the Senate Health & Human Services Committee. The bill would create a prescription drug review board in Colorado that’s charged with re...

Learn More

Weekly Policy Update: CBSA Engages on Key Legislation

CBSA took new positions on several bills in the 2021 legislative session. Here is a recap of what happened this week. New Funding for Advanced Industries Grant Program: On Tuesday, the legislature pas...

Learn More

Colorado Vaccine Distribution Update

The Colorado Department of Public Health & Environment (CDPHE) confirmed to CBSA that members of our life sciences workforce involved in the research, development, manufacturing and distribution o...

Learn More

Policy + Advocacy: Legislature Passes New Funding for Advanced Industries Accelerator Grant Program

On Tuesday, the Colorado General Assembly passed Senate Bill 42, which includes a one-time, $10 million infusion for the Advanced Industries Accelerator Grant Program. Governor Polis is expected to si...

Learn More

Weekly Policy Update: CBSA Shares Survey Insights

The CBSA Policy + Advocacy team works to engage state and federal policymakers on issues that are critical to our members and Colorado’s life sciences ecosystem. Last month, CBSA conducted a survey to...

Learn More

The Colorado Molecular Correlates Laboratory Puts Quality First

The Colorado Molecular Correlates Laboratory is dedicated to the development and implementation of predictive, prognostic and diagnostic molecular biomarker testing that will permit selection of cance...

Learn More

Weekly Policy Update: CBSA Takes Positions on New State Legislation

The Colorado state legislature returned on February 16th to continue the 2021 session, and there have already been almost 300 bills introduced so far. CBSA’s Policy + Advocacy team has been hard at wo...

Learn More

CBSA Joins Patient Community to Raise Awareness about Rare Diseases

This week, CBSA joined the Colorado Rare Action Network for Colorado Rare Disease Day. The virtual event was an opportunity to educate state legislators and the public about the challenges rare diseas...

Learn More

Weekly Policy Update: Governor Polis Delivers the State of the State

On Wednesday, Governor Jared Polis delivered his State of the State address. He started by acknowledging the challenges Colorado and the country have faced over the past year in the midst of a global...

Learn More

Weekly Policy Update: Colorado Legislative Session Resumes Next Week

The Colorado state legislature returns next Tuesday to resume the first regular session of the 73rd General Assembly. Here are a few of the issues CBSA is focused on this session. Advanced Industries...

Learn More

Weekly Policy Update: Congressional Democrats Use Budget Reconciliation, Creating Path for COVID Relief Package

On Friday, the U.S. Senate and the U.S. House of Representatives passed a budget resolution, advancing the process of budget reconciliation that will allow Democrats to pass President Joe Biden’s COVI...

Learn More

Weekly Policy Update: Colorado Releases Solicitation to Operationalize Canadian Drug Importation Program

In 2019, the Colorado General Assembly passed SB19-005, which authorized the Department of Health Care Policy & Financing (HCPF) to seek approval from the federal government to create a Canadian d...

Learn More

Cerebral Therapeutics Advances Neurological Science and Patient Outcomes

Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!

Learn More

Weekly Policy Update: President Biden Takes Immediate Action

On January 20, President Joe Biden signed a series of executive orders, just hours after taking his oath of office. In addition to reversing some of the steps taken by the Trump Administration over th...

Learn More

Weekly Policy Update: CMS Finalizes New Pathway for Medicare Coverage of Innovative Technologies

The Centers for Medicare and Medicaid Services (CMS) published a final rule this week that creates a new, voluntary pathway for immediate, national Medicare coverage for medical technologies approved...

Learn More

Weekly Policy Update: Small Business Administration Releases New Details for Paycheck Protection Program

The Small Business Administration (SBA) released new guidance this week for the next round of Paycheck Protection Program (PPP) loans. Congress authorized $284.45 billion to go towards PPP loans as pa...

Learn More

CBSA Highlights Colorado Case for U.S. International Trade Commission

CBSA submitted a letter to the U.S. International Trade Commission this week calling attention to a complaint made by Ventria Bioscience, Inc., an important member of Colorado's life sciences communit...

Learn More

Weekly Policy Update: CBSA Prepares for the 2021 Legislative Session

On January 13, the Colorado General Assembly will convene for a short time to address urgent business and then take a temporary recess, with the aim of returning to the state Capitol on February 16 to...

Learn More

Congress Passes New COVID Relief Package: What it Means for Colorado Life Sciences

Late last night Congress passed a $900 billion coronavirus aid package that will provide emergency economic relief and stimulate the nation’s economy. This is the first COVID-19 relief measure that Co...

Learn More

Neurexis Therapeutics Works to Solve an Unmet Healthcare Need

Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!

Learn More

Weekly Policy Update: December Revenue Forecast Shows More Money Than Expected to Support Recovery

Today the Governor’s Office of State Planning & Budgeting and the state’s Legislative Council presented their December economic and revenue forecasts to the General Assembly’s Joint Budget Committ...

Learn More

Colorado BioScience Association Annual Awards Celebration: Video Highlights

Colorado’s life sciences community gathered on December 9 to toast the companies and organizations driving health innovation forward. CBSA President & CEO Jennifer Jones Paton and CBSA Board Chair...

Learn More

Colorado’s Life Sciences Ecosystem Raises $1.2 Billion in 2020

Leadership During COVID-19 Accelerated Interest and Investment in Colorado DENVER – Colorado BioScience Association today announced the fourth year Colorado’s life sciences community has raised more t...

Learn More

Weekly Policy Update: COVID-19 Vaccine Distribution in Colorado

The last week has been groundbreaking for science and health innovation. On Friday, December 11, the U.S. FDA granted Emergency Use Authorization (EUA) for a COVID-19 vaccine developed by Pfizer and B...

Learn More

CBSA Applauds Senator Bennet for Legislation to Ensure Patient Access to Leading-Edge Diagnostics

Yesterday Senator Michael Bennet introduced new legislation in the U.S. Senate that aims to ensure timely Medicare coverage for new, innovative tests that detect multiple types of cancer before sympto...

Learn More

OEDIT Convenes State Legislators for Session on Advanced Industries

On Wednesday, the Colorado Office of Economic Development and International Trade (OEDIT) partnered with CBSA and the six other advanced industries to host an informational session for state legislato...

Learn More

Colorado BioScience Association Honors Life Sciences Leaders Driving Innovation Forward at Annual Awards Celebration

Inscripta Wins Company of the Year, Edgewise Therapeutics Named as Rising Star Denver, December 10, 2020 – Colorado BioScience Association celebrated the companies and organizations driving new health...

Learn More

Weekly Policy Update: Colorado Special Session Recap

The Colorado General Assembly met for a three-day Special Session this week to pass an economic stimulus package that provides support and relief to certain small businesses, education providers, and...

Learn More

CBSA Convenes Experts + Advocates to Discuss the Promise of Genomic Medicine

This week CBSA partnered with the Colorado Cancer Caucus and the Biotechnology innovation Organization (BIO) to host a discussion on the promise of genomic medicine for oncology and rare, genetic dise...

Learn More

Congratulations, Advanced Industries Accelerator Grant Recipients

Colorado BioScience Association congratulates CBSA members awarded proof-of-concept and early-stage capital grants by Colorado’s Office of Economic Development and International Trade (OEDIT). A total...

Learn More

Weekly Policy Update: Colorado Special Legislative Session + Interim Final Rule on Most Favored Nation Payment Model

Yesterday Governor Polis called a Special Session of the General Assembly to discuss an economic stimulus package that he said cannot wait until January. The session is scheduled to begin on November...

Learn More

Global Impact: Z Biotech Advances Glycoscience Research

Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!

Learn More

Governor Presents Budget Proposal to State Legislature's Joint Budget Committee

Earlier this month, Governor Polis released his $35 billion budget proposal for fiscal year 2021-22. The request included three key elements to boost Colorado’s economy and support critical investment...

Learn More

Weekly Policy Update: Colorado Dept. of Labor Releases Final Rules on Equal Pay Transparency

In September, the Colorado Department of Labor and Employment (CDLE) published proposed rules on Equal Pay Transparency providing guidance for implementation of the state’s new Equal Pay for Equal Wor...

Learn More

Colorado Life Sciences Leaders Meet with Governor Jared Polis

Colorado BioScience Association (CBSA) brought leaders from Colorado’s life sciences community together to meet with Governor Polis, Lt. Governor Primavera, and their staff.  The group had the opportu...

Learn More

Weekly Policy Update: Key Takeaways from the Colorado Election

Colorado voters were highly motivated in this year’s election. In fact, the state experienced record turnout, with over 80% of eligible voters participating in the election. As predicted, Colorado con...

Learn More

Weekly Policy Update: Polis Releases FY 2021-22 Budget Request, Prioritizes Advanced Industries Accelerator Grant Program

Today Governor Polis submitted his budget request for the 2021 – 2022 fiscal year. The proposal calls for $35.4 billion in total funds and includes three key elements that the administration believes...

Learn More

CBSA and BIO Host Webinar: Developing + Distributing a COVID-19 Vaccine

CBSA partnered with the Biotechnology Innovation Organization (BIO) to host a webinar about the ecosystem’s work to develop and deliver a safe and effective COVID-19 vaccine. The discussion featured a...

Learn More

AΩA Honor Medical Society Funds Research + Education Fellowships for Future Medical Leaders

Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!

Learn More

Weekly Policy Update: CBSA Virtual Roundtable with Congresswoman Diana DeGette

This week CBSA held a virtual roundtable with Congresswoman Diana DeGette, who represents Colorado’s first Congressional district. It was a great opportunity to showcase the critical health innovation...

Learn More

Weekly Policy Update: Polis Administration Holds Stakeholder Meeting on Canadian Drug Importation Program

On Thursday, the Department of Health Care Policy and Financing held a virtual stakeholder meeting to provide an update on the progress of Colorado’s Canadian drug importation program. The program was...

Learn More

CBSA Takes Positions on Statewide Ballot Measures Impacting Life Sciences Ecosystem

Colorado BioScience Association (CBSA) leads Policy + Advocacy for Colorado’s life sciences community. We work for a pro-innovation policy environment to accelerate the growth of our life sciences eco...

Learn More

Weekly Policy Update: Colorado Life Sciences Leaders Update Senator Bennet on Critical COVID-19 Innovations

This afternoon CBSA hosted a virtual roundtable with Senator Michael Bennet to provide updates on the innovative work underway in Colorado to defeat COVID-19. In his opening comments, the Senator talk...

Learn More

Amgen Foundation Support brings LabXchange Training to Colorado Teachers

Through the generous support of the Amgen Foundation, the Colorado BioScience Institute (Institute), in collaboration with the Harvard LabXchange creators, will begin training Colorado teachers on Lab...

Learn More

Weekly Policy Update: Colorado Dept. of Labor & Employment Issues Proposed Rules on Equal Pay Transparency

On September 29, the Colorado Department of Labor and Employment (CDLE) published proposed Equal Pay Transparency Rules (“EPT Rules”) providing guidance for implementation of the state’s new Equal Pay...

Learn More

Colorado BioScience Association Welcomes Community to Colorado Life Sciences Innovation Forum

For Immediate Release: October 1, 2020    Colorado BioScience Association Welcomes Community to Colorado Life Sciences Innovation Forum Two-Day Event Includes Unveiling of 2020-2021 BioScien...

Learn More

IMD Path Thinks Outside of the Box, Brings Strong Culture

Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!

Learn More

Weekly Policy Update: FDA Moves Forward with Final Rule on Drug Importation

Yesterday the FDA issued their final rule and guidance on the importation of prescription drugs. They were first proposed last December, and CBSA worked with other state bioscience associations to sub...

Learn More

Weekly Policy Update: State Releases Updated Economic and Revenue Forecast

This morning, the Joint Budget Committee (JBC) heard presentations on the September economic and revenue forecast from Legislative Council Staff and the Office of State Planning and Budgeting (OSPB)....

Learn More

Weekly Policy Update: President Moves Forward with Most-Favored-Nation Drug Pricing Policy

On Sunday, President Trump issued an Executive Order on a drug pricing policy called “most-favored-nation.” The order directs the Secretary of Health and Human Services (HHS) to develop and implement...

Learn More

Colorado Partners with Google and Apple to Launch Contact Tracing App

At a press conference on Tuesday, Governor Jared Polis announced that Colorado will partner with Google and Apple on a contact tracing app for COVID-19. By the end of September, any resident with a sm...

Learn More

Weekly Policy Update: CMS Issues Proposed Rule to Improve Coverage for Breakthrough Technologies

This week the Centers for Medicare & Medicaid Services (CMS) released the long-awaited proposed rule on "Medicare Coverage of Innovative Technologies." The proposed rule would make significant cha...

Learn More

Weekly Policy Update: CBSA Member PharmaJet Hosts Visit with Senator Cory Gardner

CBSA member PharmaJet hosted a visit with U.S. Senator Cory Gardner this week to showcase their needle-free technology for vaccine and therapeutic delivery. It was a great opportunity for the company...

Learn More

CBSA - All Member Meeting 2020

CBSA brought our life sciences community together for our annual All-Member Meeting on August 19, led by CBSA Board Chair Bob Reddy of Medtronic and CBSA President and CEO Jennifer Jones Paton. Bob an...

Learn More

Weekly Policy Update: CBSA Engages Congressional Delegation to Protect Life Sciences Innovation

CBSA continues to engage the Colorado Congressional delegation around an executive order that the President announced on July 24 that would limit payment for Medicare Part B drugs to the lowest price...

Learn More

Weekly Policy Update: President Trump Issues ‘Buy American’ Executive Order

President Trump recently issued an executive order intended to increase federal support for the domestic manufacture of “essential medicines,” “medical countermeasures,” and “critical inputs” through...

Learn More

Weekly Policy Update: CBSA Advocates for Additional Relief for Life Sciences Startups + Growth Companies

CBSA supports H.R. 7917, the IGNITE American Innovation Act, bipartisan legislation recently introduced to ensure innovative and entrepreneurial companies can access the necessary liquidity to continu...

Learn More

Weekly Policy Update: CBSA Meets with Congressional Offices on the VALID Act

CBSA and our members met with Senator Michael Bennet and Rep. Diana DeGette’s offices this week to discuss the Verifying Accurate Leading-edge IVCT Development (VALID) Act, recent federal legislation...

Learn More

ClinImmune Labs Change Patient Outcomes in Unique Ecosystem

Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!

Learn More

Weekly Policy Update: Energize Colorado Gap Fund Launches August 2020

The  Energize Colorado Gap Fund was created by Senate Bill 222 and will provide more than $25 million in small business loans and grants to boost small businesses impacted by COVID-19. Sole propr...

Learn More

Industry Experts Update State Policymakers on COVID-19 Efforts

Colorado BioScience Association is proud of how our life sciences ecosystem has responded to the outbreak of COVID-19. We have seen our members come together to address the crisis and commit resources...

Learn More

Weekly Policy Update: Federal Lawmakers Introduce Diagnostic Testing Bills

Recently, Colorado Representative Diana DeGette and Indiana Representative Larry Bucshon introduced two bills to increase diagnostic testing capabilities at public health laboratories, in hospitals, a...

Learn More

Weekly Policy Update: Read CBSA's 2020 Legislative Session Report

On June 15, the Second Regular Session of the 72nd General Assembly adjourned sine die, marking the end of a truly historic legislative session. During the first two months of the session, we saw the...

Learn More

Colorado BioScience PAC Educates State Candidates on Life Sciences Priorities

Last Tuesday was Colorado’s primary election, where voters decided on candidates for races including the U.S. Senate, U.S. House of Representatives, the state legislature, and other races like distric...

Learn More

ArtisanBio Cell Therapies Engineers Talent and Innovation

Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!

Learn More

Weekly Policy Update: New Small Business Loan and Grant Programs Signed into Law

On Tuesday, Governor Polis signed two state bills into law that will provide support for Colorado small businesses through low-interest loans and grants from the state. Both bills passed with bipartis...

Learn More

Weekly Policy Update: State Releases June Economic & Revenue Forecast

Today, the Joint Budget Committee (JBC) heard presentations on the June economic and revenue forecast from Legislative Council Staff and the Office of State Planning and Budgeting (OSPB). The takeaway...

Learn More

CBSA Advocates to Sustain a Supportive Tax Environment for Ecosystem

Just days before the end of the session, Colorado state legislators introduced House Bill 1420, a controversial measure that would eliminate critical tax breaks and relief for Colorado businesses of a...

Learn More

Weekly Policy Update: Legislative Session Comes to a Close - Final Week Round Up

The legislative session continued for a third week with a wave of controversial bills, including the introduction of House Bill 1420, which would eliminate critical tax breaks and relief for Colorado...

Learn More

New Data Demonstrates Life Sciences Ecosystem Growth, Impact in Colorado

Numbers Signal Steady Jobs, Salary, and Funding Gains DENVER – Colorado BioScience Association shares newly released employment and federal funding data on life sciences in Colorado, demonstrating eco...

Learn More

CBSA Board Welcomes AGC Biologics

Colorado BioScience Association warmly welcomes AGC Biologics to our state. Last week, the global CDMO announced it will invest $100 million in a large-scale biopharmaceutical manufacturing facility i...

Learn More

Weekly Policy Update: Congress Passes New Law Creating More Flexibility in the Paycheck Protection Program

On Friday, President Trump signed into law the Paycheck Protection Program Flexibility Act. The new law addresses many concerns raised by the small business community about the Paycheck Protection Pro...

Learn More

CBSA Hosts Virtual Roundtable with Congressman Ed Perlmutter

This week, CBSA hosted a roundtable with Congressman Ed Perlmutter, who represents Colorado’s seventh Congressional district. It was a great opportunity for members of our community to ask questi...

Learn More

AGC Biologics Chooses Colorado, Invests $100 Million in Boulder Facility

On behalf of Colorado’s life sciences community, CBSA is pleased to welcome Global CDMO AGC Biologics to our state. The company invested $100 million in a 300,000-square-foot facility in Boulder and w...

Learn More

Congratulations, Advanced Industries Accelerator Grant Recipients

Colorado BioScience Association congratulates CBSA members awarded proof-of-concept and early-stage capital grants by Colorado’s Office of Economic Development and International Trade (OEDIT). A total...

Learn More

AAVCOVID Vaccine Program from Mass. Eye and Ear and Mass General Enters Manufacturing Agreement with Gene Therapy Leader AveXis, a Novartis Company

AveXis, a Novartis Company, agrees to contribute the use of its gene therapy manufacturing expertise to help produce and scale novel vaccine that uses adeno-associated virus (AAV) vector for clinical...

Learn More

Weekly Policy Update: State Legislature Resumes - Week One Round Up

On May 26, the Colorado state legislature resumed the 2020 session with a condensed list of bills. Here’s a quick recap of key bills that were heard this week. House Bill 1195, Consumer Digital Repair...

Learn More

Innovative Industries Internship Program Update

Since last fall, CBSA has been advocating for an extension of the Innovative Industries Internship Program, which is set to expire July 1 of this year. The program incentivizes employers to find, hire...

Learn More

CBSA + BIO Host Webinar on COVID-19 Innovation Pipeline

On May 21, Colorado BioScience Association (CBSA) partnered with the Biotechnology Innovation Organization (BIO) to host a webinar about the COVID-19 global development pipeline and how Colorado’s lif...

Learn More

DARTNet Pairs Technology and Research to Advance Medical Knowledge

Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!

Learn More

Colorado BioScience Association Congratulates New Class of Boettcher Investigators

$1.88 million in biomedical research grant funding for 2020 Class DENVER, May 22, 2020 — The Boettcher Foundation has selected eight researchers to receive funding through the Boettcher Foundation’s W...

Learn More

In the Weeds: Joint Budget Committee + Advanced Industries Accelerator Grant Program

Since early May, the Joint Budget Committee (JBC) has been working to balance the state budget and review recommendations from the committee staff and the Governor’s Office of State Planning and Budge...

Learn More

Good News: Advanced Industries Accelerator Grant Program

We are excited to share good news about the Advanced Industries Accelerator Grant Program. Yesterday, the General Assembly’s Joint Budget Committee (JBC) decided to preserve the program and maintain a...

Learn More

Joint Budget Committee Delays Action Again on Advanced Industries Accelerator Grant Program

Last week, the Colorado General Assembly’s Joint Budget Committee (JBC) continued their work to balance the state budget and considered many of the remaining budget cut recommendations for each state...

Learn More

Weekly Policy Update: CBSA Provides Feedback on New Proposal for Antimicrobial Drug Development

Senator Michael Bennet is planning to introduce legislation that would create new incentives for the development of innovative antimicrobial drugs, called the Pioneering Antimicrobial Subscriptions to...

Learn More

CBSA Hosts Member Discussion with Congressman Jason Crow

On Wednesday, CBSA hosted a discussion with Congressman Jason Crow, who represents Colorado’s sixth Congressional district. The Congressman gave an update on his efforts to provide relief for small bu...

Learn More

Additional Support Needed: Advanced Industries Accelerator Grant Program

On Tuesday, the General Assembly’s Joint Budget Committee (JBC) delayed a vote on the Advanced Industries Accelerator Grant Program. The newest recommendation from budget committee staff would elimina...

Learn More

Weekly Policy Update: CBSA Fights to Protect the Advanced Industries Accelerator Grant Program

Earlier this week, staff analysts for the Joint Budget Committee (JBC) presented revised figure setting documents to guide the JBC as they work to balance the budget over the coming weeks. The documen...

Learn More

Your Support Needed Now – Advanced Industries Accelerator Grant Program

Colorado is facing massive budget shortfalls due to the COVID-19 pandemic. This puts the flagship funding program for life sciences in Colorado at risk. The Advanced Industries Accelerator Grant Progr...

Learn More

Meet Avidity, The "Connection" Company

Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!

Learn More

CBSA Hosts Virtual Town Hall with Senator Cory Gardner

On Monday, CBSA hosted a virtual town hall with Senator Cory Gardner. More than 65 members and leaders of Colorado’s life sciences community came together to ask questions and offer feedback about the...

Learn More

Weekly Policy Update: Governor Polis Issues Safer at Home Executive Order

On Sunday, Governor Polis issued a new Executive Order to move Colorado to the Safer at Home phase. The Safer at Home Order phases in the reopening of certain businesses over the next week, while cont...

Learn More

What the New Federal Relief Package Means for Life Sciences

On April 23, the U.S. House of Representatives passed the Paycheck Protection Program and Health Care Enhancement Act, and the following day President Trump signed the bill into law. The $484 billion...

Learn More

Colorado BioScience Association Appoints Executives from Medtronic, Amgen to Lead Board of Directors

Bob Reddy of Medtronic Enabling Technologies, Dr. Kiki Traylor of Amgen Named Board Chair and Vice Chair Denver – Colorado BioScience Association (CBSA) today welcomed new officers and members to...

Learn More

Weekly Policy Update: As Congress Considers Next Phase of Relief, CBSA Invites Members to Weigh In

Just days after President Trump signed the CARES Act into law, Members of Congress were already talking about the need for a fourth relief package to help ease the economic pain created by the pandemi...

Learn More

Weekly Policy Update: Colorado General Assembly Sets Tentative Date to Resume Session

The Colorado General Assembly’s top-ranking lawmakers from each party met on Wednesday to discuss a number of big issues they’re facing. First, legislative leadership determined that the General Assem...

Learn More

Senator Bennet, FDA Updated on Colorado COVID-19 Innovations

CBSA continues to work with federal, state and local officials to advocate for our life sciences ecosystem and facilitate connections for companies and organizations working on COVID-19. On Monday, we...

Learn More

Beginning Today – New Loans Available for Small Businesses Under CARES Act

There’s immediate relief for small businesses affected by COVID-19 under the CARES Act. New loans are available through the Paycheck Protection Program beginning today, Friday, April 3, for small comp...

Learn More

CARES Act Stimulus Package: What it Means for Life Sciences in Colorado

This afternoon, President Trump signed into law S. 3548, the Coronavirus Aid, Relief, and Economic Security (CARES) Act. The $2 trillion relief package is the largest economic stimulus measure in mode...

Learn More

Life Sciences + Statewide Stay-at-Home Order

Colorado is now under a Stay-at-Home-Order issued by Governor Jared Polis. The order requires everyone in Colorado to stay in their place of residence, except for certain necessary activities, essenti...

Learn More

Life Sciences and Stay-at-Home Orders

The City and County of Denver and the City of Boulder issued stay-at-home orders on Monday following the Governor’s directive on in-person workforce reduction during the COVID-19 pandemic. CBSA antici...

Learn More

Urgent – Open Positions with the State and Children’s Hospital

Colorado BioScience Association is working with policymakers and business leaders to support our ecosystem during the COVID-19 pandemic and offer our community’s expertise. The Governor’s team is aski...

Learn More

COVID-19: Life Sciences and the Governor’s In-Person Workforce Reduction Order

On Sunday, Governor Polis issued an Executive Order that requires all non-critical businesses in the state to reduce their in-person workforce by 50% due to the COVID-19 pandemic. It requires all non-...

Learn More

Weekly Policy Update: CBSA Supports Life Sciences Ecosystem in the Fight Against COVID-19

During these challenging times, CBSA is focused on supporting our ecosystem and its response to the COVID-19 pandemic. We continue to engage with our local, state, and federal elected officials to ens...

Learn More

Weekly Policy Update: Colorado State Legislature Suspends Session for Two Weeks

To do their part in slowing the spread of COVID-19, the Colorado General Assembly met on Saturday, March 14th and passed a Joint Resolution to temporarily adjourn until March 30. The legislature also...

Learn More

CBSA on COVID-19

Businesses and organizations here in Colorado and around the world are all managing through the impact of COVID-19 on their business operations and personal lives. Our ecosystem’s work to drive health...

Learn More

COVID-19: CBSA Business Resource Guide

Last updated: April 6, 2020 Urgent: CBSA is working with policymakers and business leaders to support our ecosystem during the COVID-19 pandemic and offer our community’s expertise. The Governor’s tea...

Learn More

Weekly Policy Update: State Legislators Introduce Bill to Extend Innovative Industries Internship Program

State legislators introduced a bill this week to extend the Innovative Industries Internship Program for another five years. The program was created in 2015 to meet the critical needs of Colorado’s lo...

Learn More

Colorado BioScience Association Offers FDA Leader’s Perspective During Keynote at Medical Device Symposium

Dr. Jeffrey Shuren to Join Conference Live via Video from Washington, D.C. DENVER – Colorado BioScience Association (CBSA) welcomes FDA’s Dr. Jeffrey Shuren via video conference to today’s annual Medi...

Learn More

Weekly Policy Update: CBSA Meets with Federal Policymakers to Discuss Coverage + Payment for Breakthrough Technologies

CBSA was in DC this week representing Colorado’s life sciences ecosystem as part of the AdvaMed Fly-in. It was a great opportunity to meet with the Colorado delegation offices and advocate for federal...

Learn More

Weekly Policy Update: Health Care Stakeholders Convene to Discuss Total Cost of Care Legislation

At a stakeholder meeting on Tuesday the Colorado Hospital Association walked through their draft proposal for a total cost of care model in Colorado. Based on programs already operating in Oregon and...

Learn More

Weekly Policy Update: Drug Price Transparency and Drug Importation Bills Pass Health Committees

CBSA was at the Colorado State Capitol again this week to voice our concerns about legislation focused on drug price transparency and prescription drug importation. House Bill 1160, Drug Price Transpa...

Learn More

Weekly Policy Update: CBSA Represents Colorado’s Life Sciences Ecosystem in Senate Committee Hearings

This week, CBSA weighed in on Senate Bill 10, Repeal Ban on Local Government Regulation of Plastics, to ensure life-saving medicines and medical devices are not impacted by local regulations on single...

Learn More

Denver Business Journal Covers New Partnership to Fund Early-Stage Life Sciences Companies

Colorado BioScience Association and Rockies Venture Club recently announced a new effort to fund early-stage life sciences companies in Colorado, funded by an Advanced Industries Accelerator Grant fro...

Learn More

Colorado BioScience Association Highlights Life Sciences Impact at the State Capitol OEDIT Executive Director Betsy Markey Keynotes CBSA’s Annual Day at the Capitol

DENVER – Colorado BioScience Association (CBSA) brings leaders from Colorado life sciences companies and organizations to the State Capitol today, February 4, 2020, to share innovation stories with le...

Learn More

Weekly Policy Update: CBSA Opposes Expanded Prescription Drug Importation Program

Last week Senator Joann Ginal introduced Senate Bill 119, Expand Canadian Prescription Drug Import Program. The bill builds on legislation that was enacted last session, that directed the Dept. of Hea...

Learn More

Weekly Policy Update: Drug Price Transparency Bills Introduced in the House and Senate

Over the past week, state legislators have introduced two drug price transparency bills that could impact our life sciences community. The first bill (SB20-107) was introduced in the Senate by Sen. Jo...

Learn More

New Investments Boost Colorado's Life Sciences Community

FOR IMMEDIATE RELEASE Rockies Venture Club and Colorado BioScience Association partner to fund Colorado Life Sciences startups in a new program backed by OEDIT Denver, CO - The Rockies Venture Club an...

Learn More

Weekly Policy Update: New Legislation Impacting Colorado’s Life Sciences Ecosystem

The CBSA team is hard at work advocating on behalf of Colorado’s life sciences ecosystem. After the first full week of the legislative session, here’s an update on where we’re engaging and why. CBSA L...

Learn More

CBSA CEO Honored by the Denver Business Journal

Congratulations to CBSA President and CEO Jennifer Jones Paton! The Denver Business Journal named Jennifer to its prestigious 40 Under 40 list, released this week. The DBJ names a class of 40 Under 40...

Learn More

Weekly Policy Update: Colorado Policymakers Outline Top Priorities for 2020 Session

Colorado lawmakers returned to the Capitol on Wednesday for the start of the 2020 legislative session, where both parties laid out their top priorities. After calling for civility and bipartisanship,...

Learn More

Weekly Policy Update: CBSA’s Priorities for the 2020 Legislative Session

January 8th marks the first day of Colorado’s 2020 legislative session, but CBSA has already been hard at work advocating on behalf of our members and the patients they serve. This session, we will co...

Learn More

Congress Votes to Repeal Medical Device Excise Tax

This week Congress voted to pass a full and permanent repeal of the medical device excise tax as part of legislation to fund the federal government through the rest of the current fiscal year. This is...

Learn More

Colorado Life Sciences Companies Raise $750 Million in 2019 Pfizer Acquisition of Array BioPharma Brings Ecosystem Total to $12.1 Billion

DENVER – Colorado’s life sciences ecosystem raised $750 million in 2019, with funds from federal and state grants, successful financing rounds and acquisitions. The record-breaking acquisition of Boul...

Learn More

Weekly Policy Update: CBSA Comments on 2020 Drug Price Transparency Draft Legislation 

Weekly Policy Update: CBSA Comments on 2020 Drug Price Transparency Draft Legislation  On Monday, CBSA sent a comment letter to Rep. Dominique Jackson and Rep. Dylan Roberts outlining our comment...

Learn More

Policy Update: CBSA Submits Recommendations to Improve the SBIR/STTR Program

Policy Update: CBSA Submits Recommendations to Improve the SBIR/STTR Program  Earlier this year, CBSA partnered with Fitzsimons Innovation Community, Gates Biomanufacturing Facility, and Sharklet...

Learn More

Colorado BioScience Association Recognizes Denver Partners for Bold Brand and New Website

Brand update delivers results for CBSA and Colorado’s life sciences ecosystem Denver – Colorado BioScience Association (CBSA) recognizes two Denver-area firms, Primavera Group and Watermark, for gener...

Learn More

Policy Update: CBSA Presents Sen. Cory Gardner with ALSIC 2019 Champion of Health Care Innovation Award

Policy Update: CBSA Presents Sen. Cory Gardner with ALSIC 2019 Champion of Health Care Innovation Award CBSA was proud to present Senator Cory Gardner with the American Life Sciences Innovation Counci...

Learn More

Policy Update: CBSA and Health Scholars Host State Rep. Shannon Bird

Learn More

CBSA Annual Awards Dinner Celebrates the Life of Adam Rubenstein

CBSA celebrated the life of Adam Rubenstein at the 16th Annual Awards Dinner.

Learn More

Policy Update: Colorado Votes

Policy Update: Colorado Votes Colorado voters decided on two major ballot measures on Election Day 2019. Proposition DD asked voters to legalize sports betting in Colorado and create a 10 percent tax...

Learn More

Colorado BioScience Association Celebrates the Strength of State’s Life Sciences Ecosystem at Annual Awards Dinner

Colorado BioScience Association Celebrates the Strength of State’s Life Sciences Ecosystem at Annual Awards Dinner Biodesix Named Company of the Year, Securisyn Medical Honored as Rising Star Denver,...

Learn More

Policy Update: Governor Jared Polis Releases Budget Proposal for FY 2020-21

Governor Jared Polis Releases Budget Proposal for FY 2020-21 Governor Jared Polis released his 2020-21 budget proposal on Friday, underscoring priorities that include expanding the state’s preschool p...

Learn More

Colorado BioScience Association Reveals New Website, Bold Brand

For Immediate Release: October 31, 2019 Colorado BioScience Association Reveals New Website, Bold Brand    Highlights Co-Opportunity, Colorado’s Collaborative, Pro-Innovation Environmen...

Learn More

CBSA Co-opportunity Means…

Health innovations from Colorado make a global impact.

Learn More

Weekly Policy Update: CBSA Co-Hosts Aurora Facility Tour for State Senator Rhonda Fields

This week CBSA partnered with CSL Behring to host state Senator Rhonda Fields for a tour of the CSL Plasma Collection Center in Aurora. On the tour, the collection center managers were able to show Se...

Learn More

Colorado BioScience Association Welcomes New Appointees to the Board of Directors

Colorado BioScience Association Welcomes New Appointees to the Board of Directors For Immediate Release: October 25, 2019 Colorado BioScience Association Welcomes New Appointees to the Board of Direct...

Learn More

Weekly Policy Update: CBSA Partners with LivaNova to host Rep. Brianna Titone

This week CBSA partnered with LivaNova to host state Rep. Brianna Titone for a tour and employee town hall at the company’s Arvada facility. It was a great opportunity to showcase the devices that are...

Learn More

Weekly Policy Update: State Releases Draft Proposal for Public Health Insurance Option

  On Monday, the Colorado Division of Insurance and the Department of Health Care Policy and Financing released a draft report on the development of the state’s plan for a public health insurance...

Learn More

Weekly Policy Update: CBSA Urges Congress to Reject Proposals that Adopt Foreign Price Controls

CBSA is committed to ensuring patients have access to the treatments they need. We appreciate the bipartisan efforts underway by the Trump Administration and Congress to provide patients relief from h...

Learn More

Weekly Policy Update: House Speaker Nancy Pelosi Releases Proposal on Prescription Drug Pricing

On September 19, House Speaker Nancy Pelosi released a long-anticipated proposal intended to reduce prescription drug prices. H.R. 3, the Lower Drug Costs Now Act of 2019, includes the following provi...

Learn More

Weekly Policy Update: Zimmer Biomet Spine Hosts Congressman Ed Perlmutter at Westminster Facility

At the end of August, Congressman Ed Perlmutter (CO-07) visited Zimmer Biomet Spine in Westminster to tour the medical education training facilities, biomechanics labs, and manufacturing area. Followi...

Learn More

2019 Rocky Mountain Life Science Investor and Partnering Conference Opens in Vail

Colorado BioScience Association connects health innovators to investors during biennial event Vail, Colo. – Colorado BioScience Association (CBSA) welcomes investors and strategic partners from across...

Learn More

Weekly Policy Update: CBSA Hosts Congressman Jason Crow (CO-06)

  This month CBSA partnered with Fitzsimons Innovation Community, Gates Biomanufacturing Facility and Sharklet Technologies to host Congressman Jason Crow (CO-06) for a campus tour and roundtable...

Learn More

Weekly Policy Update: CBSA Meets with Executive Director of OEDIT

  This week CBSA President & CEO Jennifer Jones Paton and Vice President Emily Roberts met with Betsy Markey, Executive Director of the Office of Economic Development and International Trade...

Learn More

Weekly Policy Update: Take Action! Join a New Letter Urging Congress to Prioritize Repeal of the Medical Device Tax

Last week we asked the Colorado bioscience community to take action and urge our Members of Congress to support permanent repeal of the medical device excise tax. The tax is a threat to medical innova...

Learn More

Weekly Policy Update: End the Device Tax

The Colorado BioScience Association strongly opposes the medical device tax, a 2.3% excise tax on the sale of certain medical technology that was enacted as part of the Affordable Care Act. Since its...

Learn More

Weekly Policy Update: HHS and FDA Announce Plan to Allow Importation of Prescription Drugs

This week the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) released a plan that describes the steps they will take to allow importation of certain drugs fro...

Learn More

Weekly Policy Update: Senate Finance Committee Advances Drug Pricing Package

On Thursday, the Senate Finance Committee advanced a major legislative package that includes substantial changes to Medicare and Medicaid drug reimbursement. The bill, the Prescription Drug Pricing Re...

Learn More

2019 Rocky Mountain Life Science Investor and Partnering Conference Opens in Vail

Colorado BioScience Association connects health innovators to investors during biennial event Vail, Colo. – Colorado BioScience Association (CBSA) welcomes investors and strategic partners from across...

Learn More

Weekly Policy Update: We Work For Health Summit—CBSA Urges Federal Lawmakers to Promote Medical Innovation and Protect Patient Access

This week CBSA vice president Emily Roberts joined other state advocates in Washington, DC for the We Work For Health Summit. During the two-day event, advocates met with their respective delegation t...

Learn More

Viewray to Expand to Denver, Adding 274 Jobs

Viewray, Inc., an Ohio-based medical technology company that provides high-level MRI-guided radiation technology is expanding its operations in the metro Denver area and will be hiring 274 people over...

Learn More

Weekly Policy Update: Trump Administration Pulls Rebate Rule

Last week the Trump Administration withdrew their proposed rebate rule that would have required manufacturer rebates to be passed through to patients in Part D and other government programs. The propo...

Learn More

Weekly Policy Update: Drug Pricing Bills Pass Key Senate Committees

Before the holiday, both the Senate Judiciary Committee and the Senate Health, Education, Labor, and Pensions (HELP) Committee advanced legislative packages aimed at lowering prescription drug prices....

Learn More

Weekly Policy Update: New Economic Forecast Indicates Increase in Expected Revenue Above the TABOR Cap

The Colorado Legislative Council released their updated budget and economic forecast this week, which showed a strong economy in the state of Colorado, an increase in expected revenue, and high wage g...

Learn More

New State-of-the-Art Facility Increases Agilent's Capacity to Produce Nucleic Acid-Based Therapeutics

New facility in Frederick, Colorado, to produce high-quality molecules with the potential to treat cancer and other diseases SANTA CLARA, Calif., June 18, 2019 Agilent Technologies Inc. (NYSE: A) toda...

Learn More

Pfizer to buy Colorado's Array BioPharma in deal worth $11.4 billion

Pharmaceutical giant Pfizer Inc. is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma Inc., a Colorado drug developer that has seen its shares soar since announ...

Learn More

Weekly Policy Update: CBSA Submits Comment Letter to Senate Finance Committee’s Health Task Force Urging Repeal of the Medical Device Excise Tax

Last month, leaders of the Senate Finance Committee announced the formation of several bipartisan task forces to examine 42 temporary tax provisions that expired or will expire between December 31, 20...

Learn More

CutisPharma Announces Acquisition of Silvergate Pharmaceuticals, Name Change to Azurity Pharmaceuticals

WOBURN, Mass. (Jun. 12, 2019) – CutisPharma, Inc. announced today its acquisition of Silvergate Pharmaceuticals, Inc. and the unveiling of its new corporate brand for the unified company: Azurity Phar...

Learn More

Weekly Policy Update: CBSA Attends the 2019 BIO International Convention

Last week CBSA President and CEO Jennifer Jones Paton and Vice President Emily Roberts attended the 2019 BIO International Convention in Philadelphia. The event brings together over 16,000 attendees f...

Learn More

Colorado BioScience Association Celebrates State’s Collaborative Nature

New Magazine Offers In-Depth Financing Data and Insights on Medical Device and Drug Approvals DENVER – Colorado BioScience Association (CBSA) today launched the new issue of its annual magazine, BioSc...

Learn More

Improving the Reimbursement Landscape for Medical Technology Innovators

CBSA continues to work with Congress and federal policymakers to improve the reimbursement landscape for medical technology innovators. Even when groundbreaking and innovative technologies meet FDA’s...

Learn More

27 Companies Share 6.1 Million Dollars in 2019 Advanced Industries Accelerator Grants

Colorado BioScience Association congratulates the 27 companies recently recognized as valuable investments for the entire state by the Office of Economic Development and International Trade’s (OEDIT)...

Learn More

CMS Rolls Back Harmful Proposals in Medicare Part D

Last Thursday CMS finalized a rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses, which included a number of significant changes to the proposed r...

Learn More

Weekly Policy Update: CMS Proposed Rule is a Step Forward for the Coverage of Breakthrough Technologies

In late April, the Centers for Medicare and Medicaid Services (CMS) publicly released its FY 2020 Inpatient Prospective Payment System (IPPS) Proposed Rule. The rule is a critical step forward for cov...

Learn More

Weekly Policy Update: The Final Tally - 2019 Legislative Session Comes to a Close

CBSA has worked hard this session to advocate on behalf of the industry. We’ve worked with our members and partners to advance proposals that promote patient safety, protect patient access, and enhanc...

Learn More

Weekly Policy Update: One Week Left - What Will Make It Across the Finish Line

With just over a week left in the 2019 legislative session, there are hundreds of bills left to debate and Democrats are scrambling to get their remaining priorities across the finish line. Here are s...

Learn More

CBSA Opposes Drug Importation and Continues to Advocate for Safe Policy to Reduce Patient Costs

Last week CBSA testified in the House Health and Insurance Committee in opposition to Senate Bill 005 - Import Prescription Drugs From Canada, which would require the Department of Health Care Policy...

Learn More

Weekly Policy Update: CBSA Applauds Introduction of House Bill to Permanently Repeal Medical Device Excise Tax

This week bipartisan legislation was introduced in the U.S. House of Representatives to permanently repeal the medical device excise tax. CBSA applauds the introduction of H.R. 2207, Protect Medical I...

Learn More

Weekly Policy Update: Drug Pricing Transparency Bill Introduced in Colorado, Plus CBSA Advocates in DC

This week CBSA testified in the House Health and Insurance Committee in opposition to House Bill 1296 – Prescription Drug Cost Reduction Measures. The bill requires health insurers, prescription drug...

Learn More

CBSA and BIO Honor Colorado Congressional Leaders as Innovators in Biotechnology

Senator Michael Bennet, Congresswoman Diana DeGette Recognized as Champions of Life Science Washington, D.C. (April 4, 2019) – Colorado BioScience Association and Biotechnology Innovation Organization...

Learn More

Weekly Policy Update: CBSA Raises Concerns about Importing Drugs From Canada, Plus A Full Review of this Month In Policy

This week President & CEO Jennifer Jones Paton spoke with 630 KHOW’s Krista Kafer about CBSA’s opposition to Senate Bill 5, which would create a Canadian drug importation program in Colorado. Thro...

Learn More

Weekly Policy Update: Colorado State Budget and Forecast, Plus CBSA Voices Concerns on Drug Pricing Legislation

Last week the non-partisan Legislative Council published the forecast for the economy and state government revenue through FY 2019-20. The forecast showed that while the economy will continue to grow...

Learn More

Weekly Policy Update: Family Medical Leave Insurance Program and the President's Proposed Budget

On Wednesday Senate Bill 188, FAMLI Family Medical Leave Insurance Program, was heard and passed out of the Senate Committee on Business, Labor & Technology. The bill would create a state-run fami...

Learn More

Weekly Policy Update: Colorado BioScience Association’s Annual Day at the Capitol

This week CBSA held our annual Day at the Capitol event, bringing healthcare innovators to the state Capitol to highlight the discoveries and advancements taking place in Colorado to improve the healt...

Learn More

Colorado BioScience Association Explores New Possibilities for Medtech at Annual Symposium

Medical device industry leaders to focus on blockchain technology, M&A trends and federal policy DENVER – Colorado BioScience Association (CBSA) focuses on the opportunities offered by blockchain...

Learn More

Weekly Policy Update: AdvaMed Fly-In and the Monthly Report

This month CBSA Vice President Emily Roberts met with Members of the Colorado Congressional delegation as part of the AdvaMed State Medical Technology Alliance (SMTA) Fly-In. This event brings togethe...

Learn More

Weekly Policy Update: CBSA and LivaNova Partner to Host Senator Cory Gardner

This week CBSA partnered with LivaNova to host Senator Cory Gardner at LivaNova’s Arvada facility. The event included a brief meeting with the Senator and his staff, followed by a tour of the facility...

Learn More

Colorado BioScience Association connects lawmakers to patient-focused innovators at Capitol event

New results highlight success of state-funded grant program for early-stage life science companies DENVER – Colorado BioScience Association (CBSA) brings healthcare innovators to the state Capitol to...

Learn More

Weekly Policy Update: CBSA Opposes House Bill 1131, Prescription Drug Cost Education

This week, CBSA attended a stakeholder meeting on House Bill 1131, Prescription Drug Cost Education. As the bill is currently written; it requires a drug manufacturer, wholesaler, agent or an employee...

Learn More

Weekly Policy Update: Trump Administration Takes Step to Encourage Direct Discounts to Patients

On Tuesday President Trump gave his State of the Union address, in which he described the need to rein in health care costs as a major priority. The President also laid out an ambitious health care ag...

Learn More

Colorado BioScience Association Appoints Emily Roberts as New Vice President

Roberts to Oversee Policy and Communications at Life Science Organization DENVER – Colorado BioScience Association (CBSA) announces the appointment of Emily Roberts to vice president. Roberts takes ov...

Learn More

Weekly Policy Update: Prescription Drug Importation and CBSA’s Day at the Capitol

Yesterday the Colorado BioScience Association testified in opposition to Senate Bill 005, which tasks the department of health care policy and financing to design a program to import prescription phar...

Learn More

Weekly Policy Update: Colorado Bioscience Championed in Denver Business Journal

Colorado BioScience Association is focused on increasing our companies’ access to capital and highlighting the innovative work coming out of our state. Our team recently collaborated with the Denver B...

Learn More

Weekly Policy Update: Importing Drugs and the Governor's Budget

Last week CBSA took an opposition position to Senate Bill 005 – Import Prescription Drugs from Canada. As a reminder this bill would create the "Colorado Wholesale Importation of Prescription Drugs Ac...

Learn More

Weekly Policy Update: New General Assembly, Inauguration, and Bill Introductions

This marks the first full week of the 72nd First Regular Session of the Colorado General Assembly. It was a busy week with bill introductions, Governor Polis’ Inauguration and the State of the State (...

Learn More

Weekly Policy Update: CBSA’s Policy Priorities for 2019

Today, January 4, 2019 marks the first of 120 days of the 72nd General Assembly. CBSA looks forward to advocating on behalf of our members, industry and the patients we serve. We also look forward to...

Learn More

Colorado Bioscience Companies Raised $1 Billion in 2018

International Investors Contributed to the State’s Largest Financings DENVER – Colorado’s life science sector raised $1 billion in 2018, entering a second year of fundraising exceeding the $1 billion...

Learn More

Weekly Policy Update: More Medical Device Tax News and the 2018 Farm Bill

TheHouse Ways and Means Committee this week released a new extenders package which included a 5-year extension on the medical device excise tax moratorium. The 2.3% levy on the sale of prescribed medi...

Learn More

Weekly Policy Update: Protecting Medicare Beneficiaries and Medical Device Tax Work

A recent proposal by the Centers for Medicare & Medicaid Services (CMS) would implement an unprecedented Part B demo that could harm Medicare beneficiaries. We believe this would alter the entire...

Learn More

Weekly Policy Update: November Recap

The November Focus newsletter was published this afternoon with Jennifer’s recap of the full month in policy news. Topics covered include: November Elections At the federal level Republicans have reta...

Learn More

Weekly Policy Update: Leadership Elections in the Colorado General Assembly

With final certification of ballots by the Secretary of State the final tally for the Democrats in the House is 41, leaving Republicans with only 24 seats. Democrats in the Senate hold the majority by...

Learn More

Weekly Policy Update: Election Report

Federal In the Senate, Republicans have retained their majority. The Republicans control 51 seats, the Democrats 44. In the House, Democrats will take the majority by more than 25 seats. Democrats con...

Learn More

Colorado BioScience Association Ignites the Future at Fifteenth Annual Awards Dinner

miRagen Named Company of the Year, Inscripta Honored as Rising Star DENVER – Colorado’s life science sector gathered on November 8 at the Hyatt Regency in Denver to honor the bioscience companies, lea...

Learn More

Colorado BioScience Association Appoints Jennifer Jones Paton as New President and Chief Executive Officer

Jones Paton Promoted to Lead Life Science Organization After Broad Search DENVER – Colorado BioScience Association (CBSA) announces the promotion of Jennifer Jones Paton to president and chief executi...

Learn More

Weekly Policy Update: An October Recap

This week, the October Focus newsletter was published for a more detailed look at policy, and other issues, please read Jennifer’s monthly policy update. Some of the featured content includes: GET OUT...

Learn More

Weekly Policy Update: Get Out and Vote!

We know elections are important and that they shape the outcomes of our State, the economy and ultimately impact our industry, bioscience. The Election takes place on November 6, 2018. We encourage yo...

Learn More

Weekly Policy Update: Bills Banning Pharmacy Gag Clauses

Last week President Trump signed two bills (Patient Right to Know Drug Prices Act and Know the Lowest Price Act) into law that ban gag clauses that were called for in the American Patients First bluep...

Learn More

Colorado BioScience Association to Honor Leading Companies and Life Science Pioneers at Awards Dinner

ArcherDX, MiRagen, Biodesix Named Finalists for Company of the Year Award; Double Helix, Impressio and Inscripta Nominated for Rising Star Award DENVER – Leaders of Colorado’s bioscience sector gather...

Learn More

Weekly Policy Update: Bioscience in Recent National and International News

A quick recap of bioscience in recent national and international news. President Trump recently signed a bill prohibiting pharmacy benefit managers from imposing “gag orders” on pharmacists that preve...

Learn More

Prima-Temp Has Acquired Kindara, a Fellow Boulder-Based Women’s Healthtech Company

Prima-Temp, a women's healthtech company, has acquired Kindara, another Boulder-based women’s healthtech company. Kindara makes an app and Bluetooth-connected thermometer to help women track their fer...

Learn More

Weekly Policy Update: Advancing Innovation in Digital Health

Over the last year, in fact, FDA Commissioner Scott Gottlieb has put an emphasis on speeding up the process in getting technology and medications out to the public. This is evidenced by the new Pre- C...

Learn More

Weekly Policy Update: The September Report

Today, the September Focus newsletter was published for a more detailed look at policy, and other issues, please read Jennifer’s monthly policy update.

Learn More

Weekly Policy Update: Advocating for Medicare Part D

The Colorado Bioscience Association along with We Work for Health Colorado, Epilepsy Foundation, Colorado Gerontological Society, Scleroderma Foundation, Rocky Mountain Stroke Center and the Colorado...

Learn More

Colorado BioScience Association Congratulates Cetya Therapeutics, Winner of Venture Showcase

Pitch competition wrapped up CBSA’s Colorado Life Science Innovation Forum DENVER – Colorado BioScience Association named Cetya Therapeutics the winner of its venture showcase at the Colorado Life Sci...

Learn More

Weekly Policy Update: Dianne Primavera and Lang Sias Address the Colorado Life Science Innovation Forum

The Colorado Life Science Innovation Forum is filling the Westin Westminster with interesting speakers, enlightening panelists, and Colorado’s two Lieutenant Governor candidates throughout the day tod...

Learn More

Colorado BioScience Association Welcomes Major Party Gubernatorial Running Mates to Colorado Life Science Innovation Forum on Friday

Dianne Primavera and Lang Sias to share their views on the economic outlook for the state’s bioscience industry DENVER – The Colorado Life Science Innovation Forum, the state’s largest gathering of bi...

Learn More

Weekly Policy update: Lieutenant Governor Candidates At The Colorado Life Science Innovation Forum and The State of Medicare

Colorado Life Science Innovation Forum – Keynote Featuring Remarks by Gubernatorial Running Mates Join CBSA on September 14th at the Colorado Life Science Innovation Forum.Our keynote lunch speakers i...

Learn More

Weekly Policy Update: A Month In Policy and Bioscience In the News

Today, the August Focus newsletter was published for a more detailed look at policy, and other issues, please read Jennifer’s monthly policy update. BIOSCIENCE IN THE NEWS  Energy and Commerce Ne...

Learn More

CBSA Forum Highlights Global Impact of Colorado’s Life Science Innovators

Colorado Life Science Innovation Forum brings national thought leaders and Colorado executives together DENVER – Colorado BioScience Association (CBSA) hosts the state’s largest gathering of bioscienc...

Learn More

Weekly Policy Update: The FDA’s Initiatives For Medical Devices and the Upcoming Gubernatorial Candidate Forum

FDA releases three important initiatives for medical device development, innovation and safety The FDA announced it is taking steps to advance innovation and surveillance for medical devices through t...

Learn More

Weekly Policy Update: FDA Releases New Draft Guidance and the Midwest BIO CSBA Retreat

FDA Releases New Draft Guidance to advance and modernize oncology drug trials In the FDA’s ongoing effort to modernize and create a more efficient approval process, last Friday the FDA released their...

Learn More

Weekly Policy Update: FDA Funding and Other News

FDA Receives Funding in Senate Passed Appropriations Bill Last week the U.S. Senate overwhelmingly passed a $154.2 billion spending bill that includes more than $3 billion for the FDA. When industry f...

Learn More

Weekly Policy Update: Medical Device Tax and Colorado State Budget

  Scott Larson, VP, Legal and General Counsel, Terumo BCT; Jenna Hutchins, Territory Manager, ResMed; Congresswoman Dianna Degette; April Giles, President, CBSA; Jonathan Toronto, Vice President,...

Learn More

Weekly Policy Update: House Repeals Medical Device Tax

On behalf of Colorado BioScience Association thank you for your efforts to secure a yes vote on H.R. 184 - Protect Medical Innovation Act of 2017. We appreciate the time you took to advocate to your r...

Learn More

Weekly Policy Update: Full Repeal of the Medical Device Tax Advocacy

This has been another week with persistent advocacy for full repeal of the Medical device tax in standalone legislation. A permanent repeal of the medical device excise tax remains a top priority for...

Learn More

Colorado BioScience Association Announces Departure of President & CEO, April Giles

Board of Directors to Begin National Search for Replacement DENVER – Colorado BioScience Association (CBSA) announces the departure of longtime President & CEO April Giles. She served CBSA for mor...

Learn More

Weekly Policy Update: Medical Device Tax Advocacy and the CACI Legislative Candidate Interviews

CBSA continues to advocate for a full repeal of the Medical device tax in standalone legislation. A permanent repeal of the tax remains a top priority for CBSA and Colorado's medtech innovators. While...

Learn More

Weekly Policy Update: Meeting with Congresswoman Degette

This week Colorado BioScience Association along with AdvaMed, our Board Chair Scott Larson at Terumo BCT, Zimmer Biomet and ResMed met with Congresswoman DeGette. The meeting offered a great opportuni...

Learn More

Weekly Policy Update: Primary Elections, Congratulating Sen. Gardner, and Drug Pricing

2018 COLORADO PRIMARY ELECTION With the anticipated Colorado Primary Election this week, we learned the long-awaited results of who would be our top two democratic and republican candidates for Govern...

Learn More

Weekly Policy Update: FDA Releases Important Guidances

The FDA recently announced the release of important guidances, “Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities–Questions and Answers,” and “Medical...

Learn More

Weekly Policy Update: Drug Pricing News

This week HHS Secretary Alex Azar appeared in front of the Senate Health, Education, Labor and Pensions Committee for a hearing on drug pricing. Secretary Azar’s prepared testimony in large part summa...

Learn More

Colorado BioScience Association Highlights Innovative Spirit, Collaborative Culture in Colorado

Annual Bioscience Colorado Magazine Profiles Leaders, Incubators and Ecosystems Colorado BioScience Association (CBSA) launched the new issue of its annual magazine, Colorado Bioscience: Igniting the...

Learn More

Weekly Policy Update: BIO International Convention and Voter Registration

This week CBSA President and CEO April Giles and Vice President Jennifer Jones returned from the 2018 BIO International Convention in Boston, Massachusetts. This annual trip is a great opportunity to...

Learn More

Weekly Policy Update: BIO International Convention and Voter Registration

POLICY UPDATES Yesterday the May Focus newsletter was published for a more detailed look at policy, and other issues, please read Jennifer’s monthly policy update in May’s Focus newsletter. 2018 BIO I...

Learn More

Weekly Policy Update: The Colorado Experience, Tariff Advocacy, and FDA Funding News

COLORADO EXPERIENCE – BOULDER This week Jennifer Jones, Vice President of the Colorado BioScience Association, participated in the Denver Metro Chamber Leadership Foundation’s Colorado Experience two-...

Learn More

Weekly Policy Update: A Quick Review of President Trump’s Prescription Medication Plan

Last Friday President Trump unveiled his administration’s plan to help make prescription drugs more affordable for patients. The blueprint called “American Patients First" builds on the president's 20...

Learn More

Coming Together as a Community

Collaborating on True Transparency to Benefit Patients Our state’s bioscience innovators work to create wearable devices to help make us healthier, develop drugs that could save a loved one from cance...

Learn More

Weekly Policy Update: Industry Defeats Harmful Transparency Measures at the Capitol

CBSA had a busy legislative session advocating on behalf the industry against transparency measures that stood to stifle bioscience innovation in Colorado and failed to provide the relief patients nee...

Learn More

Making a Difference for Patients

Meet the Colorado Leaders Developing Breakthrough Cures and Treatments Colorado’s researchers, innovators and entrepreneurs work to develop breakthroughs start locally and impact globally. Our sector’...

Learn More

Weekly Policy Update: HB-1358 Dies in Committee and Ongoing Transparency Advocacy

Advocating at the Capitol Today, April Giles, CBSA president & CEO testified in the House Health, Insurance, & Environment committee in opposition to HB18-1358 - Health Care Charges Billing Re...

Learn More

Prescription Drugs: Just the Facts

As the Colorado State Legislature considers House Bill 18-1260, Drug Price Transparency, a lot of claims and opinions are circulating in our state about the drivers of health care costs. Prescription...

Learn More

Weekly Policy Update: Action on Two Bills and Advocacy in DC

UNDER THE GOLD DOME This week, HB18-1135: Extend Advanced Industry Export Acceleration Program passed the Colorado House of Representatives and next week it moves to the Senate. This bill extends the...

Learn More

Colorado BioScience Association Names New Board Members

Leaders represent CereScan, Ocugen, Prevacept Infection Control, Sharklet and Zimmer Biomet DENVER – April 23, 2018 – Colorado BioScience Association (CBSA) announces new members elected to its board...

Learn More

Driving Down Drug Costs

Three Solutions to Help Patients and Support Innovators Current proposals under consideration at the Colorado State Legislature propose a simple fix for a complex issue. We agree, patients and their f...

Learn More

Weekly Policy Update: CBSA Takes Positions on Additional Bills, Transparency News, and China Tariffs

UNDER THE DOME The Colorado BioScience Association took formal positions on three bills this week. With 18 working days left of session we continue to evaluate and make recommendations on legislation...

Learn More

Weekly Policy Update: CO House Votes on Prescription Drug Price Transparency Bill Monday!

Colorado House Votes next week on Prescription Drug Price Transparency Bill (HB18-1260) CBSA continues to advocate against House Bill 1260, Prescription Drug Price Transparency. The bill could stifle...

Learn More

Understanding Bills at the Legislature

Where Do Patients Fit In? Colorado families need access to medicines and health care at affordable prices. That’s why Colorado BioScience Association supports True Transparency. This means considering...

Learn More

Weekly Policy Update: Colorado Budget and Forecast, plus a True Transparency update

CO State Budget & March Forecast Transportation, Education, PERA, and opioid addiction are a few of the areas that will receive funding in the $28.9 billion state budget package passed by the Colo...

Learn More

How do drug companies determine prices?

The Value of Innovation When you stop in to the pharmacy to pick up a prescription, you may wonder how manufacturers determine the price you pay. You may think the drug maker maintains full control ov...

Learn More

Weekly Policy Update: Advocacy Around Drug Transparency Issues, an Opportunity To Be Heard By the Next Governor, and the Omnibus Spending Bill

This week CBSA testified in opposition to House Bill 1009, Diabetes Drug Pricing Transparency Act 2018. The bill was heard in the House Health, Insurance and Environment Committee and passed on a part...

Learn More

What are Pharmacy Benefit Managers?

PBMs Largely Determine How Much Your Medicines Cost With public policy debate at Colorado’s State Capitol focused on prescription drug price transparency, it’s critical for our decision makers and the...

Learn More

Weekly Policy Update: Continuing the Transparency Advocacy and a Business Guide for the Governor

CBSA Continues to Advocate in Opposition to House Bill 1260, Prescription Drug Price Transparency As reported last week, House Bill 1260, Prescription Drug Price Transparency passed on a party line vo...

Learn More

Understanding the Costs of Your Rx

Who Determines What You Pay for Prescription Medicines? When you visit your pharmacy counter to pick up a prescription, do you know who determines the final cost you pay? Many people think it’s one co...

Learn More

Weekly Policy Update: Prescription Drug Price Transparency

Transparency at the Colorado State Capitol This week CBSA testified in opposition to House Bill 1260, Prescription Drug Price Transparency. The bill was heard in the House Health, Insurance and Enviro...

Learn More

How Do Innovative Medicines Save Lives?

Transforming How We Treat and Cure Diseases We support true transparency, which means working together to provide patients access to affordable medicines. While a few bad actors make headlines, millio...

Learn More

Weekly Policy Update: House Bill 1260 Prescription Drug Transparency, plus the Advamed Fly-In in Washington, D.C.

Urge a NO Vote on HB 1260, Prescription Drug Price Transparency This week CBSA opposed a new bill introduced by the Colorado House that could adversely impact the Colorado bioscience industry, Ho...

Learn More

What is True Transparency?

Working Together to Provide Access to Affordable Medicines It’s time to start a community conversation about prescription medicines and the out-of-pocket costs for patients. Several bills under consid...

Learn More

Weekly Policy Update: Positions on three bills, true transparency, and a visit to D.C.

UNDER THE DOME The Colorado BioScience Association took formal positions on three bills this week and we continue to evaluate and make recommendations on legislation being introduced. Outlined below a...

Learn More

Weekly Policy Update: True Transparency and Medicare Stakeholder Input

CBSA promotes the interests of more than 725 bioscience companies and their 30,000 employees. We work every day to create an innovation-friendly business environment ensuring that as an industry we de...

Learn More

Colorado BioScience Association highlights state’s life-saving medical breakthroughs for lawmakers

Annual event brings health care innovators to share successes with legislators at the Capitol DENVER – Colorado BioScience Association (CBSA) brings life science innovators to meet lawmakers and highl...

Learn More

Weekly Policy Update: Colorado BioScience Association Highlights State's Life-Saving Medical Breakthroughs for Lawmakers

This week we had a successful CBSA Day at the Capitol. At the event we heard from Lieutenant Governor Donna Lynne on her top priorities, outlook on the opioid and substance abuse task force and the fu...

Learn More

Friday Policy Updates 2/2/2018

As things continue to be active and heat up over at the Colorado State Capitol, this week the Colorado BioScience Association took formal positions on three bills, while continuing to evaluate and mak...

Learn More

Friday Policy Updates 1/26/2018

UNDER THE DOME The CBSA team will be busy this legislative session working on bills that stand to have a negative impact on our industry, with an anticipated 7 healthcare transparency bills aimed at l...

Learn More

Colorado BioScience Association Highlights Medtech Disruption

Annual Medical Device Symposium discusses industry growth, innovation and federal policy outlook DENVER – On Jan. 30, 2018, the Colorado BioScience Association (CBSA) will host more than 80 medtech le...

Learn More

Colorado BioScience Association Applauds Suspension of the Medical Device Tax and Reauthorization of CHIP

  Congress delays medical device tax for two years Last night, the President signed a continuing resolution (CR) package, which includes a two-year suspension of the device tax retroactive to Dec...

Learn More

Friday Policy Update 1/19/2018

Another week goes by and we continue to strongly advocate for the repeal of the medical device excise tax. This week in DC, the House passed the continuing resolution (CR) to fund the government until...

Learn More

Millennials: Training Talent

State-Funded Program Connects Interns to Bioscience Careers Colorado’s commitment to growing a strong bioscience workforce begins with training up-and-coming talent. A state-funded program focused on...

Learn More

Friday Policy Updates 1/12/2018

UNDER THE GOLD DOME – THE 71ST GENERAL ASSEMBLY The 2018 Colorado Legislative session started this week and kicked off with several industry related health care bills. The CBSA team is already hard at...

Learn More

miRagen: Comprehensive, microRNA Targeted Therapies

Tiny Molecules Modulate Cellular Processes and Can Re-Program Cells Involved in Disease Bill Marshall was in Vienna, Austria, when he got the news. A prominent researcher had, for the first time, foun...

Learn More

Inocucor Raises $9.5 Million in Series B Second Close Led by Pontifax AgTech, Raising Total Proceeds of Series B Financing to $38.5 Million

Inocucor Raises $9.5 Million USD ($12.1 Million CAD) in Series B Second Close Led by Pontifax AgTech, Raising Total Proceeds of Series B Financing to $38.5 Million USD ($50.9 Million CAD) Ben Belldegr...

Learn More

Friday Policy Updates – 1/5/2018

Under the Gold Dome – The 71st General Assembly The 2018 Colorado Legislative session begins next Wednesday, January 10th! The CBSA team will be busy advocating on behalf of the Colorado Bioscience in...

Learn More

Millennials in Colorado

Expanding our Workforce, Inspiring Our Companies Colorado boasts the fastest-growing Millennial population in the United States. This large demographic group is generally recognized as Americans born...

Learn More

At the Center of Everything

Our Location Gives BioScience Companies an Advantage Many factors contribute to Colorado’s reputation as an exceptional place to start, grow, commercialize or relocate a life science business. Our col...

Learn More

2017 Breaks Bioscience Records

$1.2 Billion Year Doubles Amount Raised in 2016 Colorado’s life science companies raised a record $1.2 billion in 2017, doubling the funds raised in the previous year. The funding came through venture...

Learn More

Sharklet Moves Out of the Startup Scene

Company Readies for Global Commercialization Sharklet has turned a corner. For the last 10 years, the startup company has worked to develop the chemical-free, micropatterned coating it pioneered to no...

Learn More

Regenerative Medicine in Colorado

How Researchers and Entrepreneurs are Advancing Human and Animal Health From treating painful skin conditions in children with IPS cells to using stem cells to improve quality of life for injured peop...

Learn More

Ready for Retirees

How the Sector is Preparing for the State’s Shifting Demographics Colorado consistently ranks as a top destination for retirees. With Baby Boomers reaching retirement age at the rate of 10,000 per day...

Learn More

TranS1: Innovative Products and Partnerships

Supporting Spine Surgery’s Invention Engine Minimally invasive spine surgery sounds like an oxymoron. But that’s precisely the goal at TranS1, headquartered in a restored Victorian home in Denver’s hi...

Learn More

Champions for Bioscience

Accelerating Industry Success through Advocacy The CBSA team leads advocacy efforts on behalf of the industry and our members. We work every day to create an innovation-friendly business environment....

Learn More

‘It’s All About the Kids’

Children Inspire the Team at Silvergate Pharmaceuticals As a pharmacist managing some of the largest consumer pharmacies in the country, Frank Segrave saw a need. The majority of medications on his sh...

Learn More

Diversity Suits the C-Suite

At Biodesix, Female Executives ‘Shake Things Up’ to Drive Growth Anyone who works in bioscience knows there are few women in executive leadership roles. Although women come into the industry at the sa...

Learn More

Collaborative by Nature

A Commitment to Working Together Supports Success There’s something different about Colorado. It’s more than our beautiful natural surroundings and abundant sunshine, favorable business climate and ta...

Learn More

Smart, Hard-Working and Happy

A Talented Workforce Powers Colorado’s Bioscience Industry Bright, passionate people make Colorado the ideal place for bioscience investment. Our state attracts leading talent from around the globe an...

Learn More

AlloSource Strives to Advance Healing

Colorado-based company balances unique mission with medical innovation AlloSource® began with a simple principle: to transform tragedy into possibility. Since that moment nearly 25 years ago, the comp...

Learn More

i2 Pharmaceuticals: Boulder Based, Global Reach

Pioneering Research to Solve the Drug Discovery Puzzle Creating an effective drug to treat disease is a bit of a puzzle. Researchers shape many molecular pieces and fit them together into a therapeuti...

Learn More

Quantifying Good Health in Colorado

Using Big Data to Improve Quality of Life Over the course of one person’s life, he or she may generate more than 12 terabytes of personal health data. If you were to store that information, it would b...

Learn More

Federal Labs in Colorado

Our State’s 33 Labs Make a $2.6 Billion Impact On any given day in Colorado, scientists at federal labs including the CDC in Fort Collins, NOAA in Boulder and NREL in Golden are studying diseases that...

Learn More

Boettcher Foundation Helps Early-Career Scientists

Funding Propels Investigators’ Research The Boettcher Foundation launched its Webb-Waring Biomedical Research Awards with the goal of helping early-career investigators advance their research to a poi...

Learn More

RxREVU Modernizes Prescription Management

Digital Health Platform Informs Prescribing Decisions In the center of Denver’s construction chorus—a sign of the city’s recent economic boom—CEO Carm Huntress, and his team at RxRevu have their own r...

Learn More

Precision Medicine in 3D

Printing the Future of Medicine Precision medicine often happens invisibly, in the nuclei of cells, in the dances of proteins, in the bowels of sequencers, in the processing cores of computer servers....

Learn More

8TH FOR DEVICE AND DIAGNOSTICS EMPLOYMENT

COMPANIES HIGHLIGHT THE INNOVATION HAPPENING HERE From global manufacturing powerhouses to inventive startups seeking to transform patient care, hundreds of medical device companies call Colorado home...

Learn More

SomaLogic’s Team Unlocks the Potential of Proteins

  Meet the Leaders Working to Develop a Breakthrough in Precision Medicine Sheri Wilcox has no regrets. As a post-doctoral research fellow in 2000, Wilcox was living in Michigan and on the verge...

Learn More

MBio Diagnostics to Commercialize Portable Lab Device

Boulder Company Uses LightDeck Technology for Mobile Disease Detection Chris Myatt knew he was on to something. At a conference in 2005, he met a scientist with a simple handheld prototype designed to...

Learn More

Why Choose Colorado?

What makes Colorado an ideal state for bioscience? Our state’s 300 days of sunshine a year and educated workforce appeal to homegrown companies and those looking to relocate. Our top five list, part o...

Learn More

Colorado Funds Bioscience Breakthroughs

Colorado promotes growth and sustainability for the state’s nine identified Advanced Industries, which make up 30% of the Centennial state’s economy, through a state-led Advanced Industry (AI) Acceler...

Learn More

Colorado BioScience Association Recognizes 2017 Boettcher Investigators

DENVER, June 13, 2017 — The Colorado BioScience Association on Tuesday commended the newest class of Boettcher Investigators and expressed its gratitude to the Boettcher Foundation for its continued s...

Learn More

PMB and Montgomery Street Partners announce approval on the first speculative purpose-built life sciences project in Boulder County, CO

This new 365,000 sq. ft. facility in Boulder County will break ground in Q2 of 2023 and complete in Q3 of 2024 PMB, a leading healthcare real estate developer, in partnership with Montgomery Street Pa...

Learn More

Think Bioscience Raises $17M in Oversubscribed Seed Round to Develop Small Molecule Drugs that Hit Undruggable Proteins

Funding will enable Think Bioscience to expand its drug discovery platform and advance its internal drug development programs.  Think Bioscience (“Think”), a synthetic biology company focuse...

Learn More

HepQuant Awarded COLA Accreditation for meeting US Clinical Laboratory Improvement Act (CLIA) and other Regulatory Requirements

HepQuant, LLC,  a Denver, Colorado-based company with a unique, patented and patent-pending technology for evaluating the liver in patients with chronic liver disease, today announced that the HepQuan...

Learn More

AGC Biologics Supports Altheia Science’s Gene Therapy Programs

AGC Biologics, today, announced a new partnership with Altheia Science. Through this partnership, Altheia Science will advance its development of autoimmunity treatments, focused on modulati...

Learn More

Terumo Blood and Cell Technologies collaborates with Eliaz Therapeutics in the development and commercialization of a novel therapeutic apheresis treatment for acute kidney injury (AKI)

Acute kidney injury (AKI) and sepsis-induced acute kidney injury (S-AKI) are life-threatening conditions, with many patients dying and others left with long-term kidney damage requiring lifelong dialy...

Learn More

SomaLogic acquires DNA nanotechnology leader Palamedrix to develop the next-generation SomaScan® Assay

SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced it entered into an agreement to acquire Palamedrix, Inc., an innovator in DNA nanotechnology. Palamedrix pro...

Learn More

Cerebral Therapeutics, Inc. Secures $40 Million Series C Financing

Cerebral Therapeutics, a clinical-stage pharmaceutical company pioneering therapies for neurological diseases, announced today $40 million in Series C funding led by Lynx1 Capital Management with part...

Learn More

Weekly Policy Update: Senate Prescription Drug Pricing Legislation

Democrats in the U.S. Senate continue to negotiate an economic package that advances President Joe Biden’s key priorities. Prescription drug pricing legislation that would drastically alter the Medica...

Learn More

Securisyn Medical Announces Strategic Manufacturing and Distribution Partnership with SunMed Group Holdings

Securisyn Medical LLC, (“Securisyn” or the “Company”), an emerging medical device company dedicated to enhancing ventilated patient safety and broader smooth tube and catheter securement, and SunMed G...

Learn More

Philips Incorporates Biodesix Blood-based Proteomic Nodule Risk Assessment Testing into Lung Cancer Orchestrator to Advance Early Lung Cancer Diagnosis

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has teamed up with Biodesix, Inc. (Colorado, U.S.) (Nasdaq: BDSX), a leading data-dri...

Learn More

Morgridge Family Foundation gifts $3M to CSU Spur and College of Agricultural Sciences

The Morgridge Family Foundation has imparted a transformational gift of $3 million to support the Colorado State University College of Agricultural Sciences and educational program...

Learn More

Biodesix Announces Research Agreement with Top US Cancer Center

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it intends to develop a new novel minimal residual disease (MRD) te...

Learn More

Watchmaker Genomics Raises $40M Series A Financing to Accelerate Growth and Expand Clinical Sequencing Product Offerings

Watchmaker Genomics, a life sciences company specializing in the development of high-stringency applications focused on the reading, writing, and editing of DNA and RNA, today announced it had secured...

Learn More

Brickell Biotech Doses First Subject in Phase 1 Study of DYRK1A Inhibitor BBI-02

Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription...

Learn More

AGC Biologics Invests in Viral Vector Suspension at New U.S. Campus

AGC Biologics today announced it is adding viral vector suspension technology and capacity for the development and manufacturing of gene therapies at its commercial-grade campus in Longmont, Col., USA...

Learn More

Weekly Policy Update: Legislative Session Comes to a Close This Week

The legislative session is scheduled to end this Wednesday, May 11th. As we enter these final three days, the CBSA team continues to weigh in on key legislation and advocate on behalf of our life scie...

Learn More

New 450K-square-foot life science campus planned in Broomfield

Developer Scott Caldwell says life science companies needed this space "yesterday." Find out more in the Denver Business Journal article. A rendering of plans for Colorado Research ExchangeLINCOLN PRO...

Learn More

Umoja Biopharma Announces Activation of First ENLIGHTen Phase 1 Trial Site in Study of UB-TT170, a TumorTag that Targets Folate Receptors to Mark Tumors for Clearance by CAR T Cells

Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune cells in vivo for patients with solid and hematologic malignancies, announced...

Learn More

Brickell Biotech Announces Sale of Sofpironium Bromide to Botanix Pharmaceuticals

Brickell Biotech, Inc., a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of autoimmun...

Learn More

EvoEndo Poised to Transform Clinical Endoscopy Practice with the EvoEndo® Single-Use Unsedated Transnasal Endoscopy (TNE) System

EvoEndo®, Inc. (“EvoEndo”), a medical device company which developed a single use system that allows for unsedated Transnasal Endoscopy (TNE), has announced the completion of an $8.4 million Series A...

Learn More

CordenPharma Receives Supplier Recognition Award From Esperion

CordenPharma is honored to announce the receipt of a Supplier Recognition Award from Esperion Therapeutics that was presented by Esperion’s Sr. Vice President of Manufacturing Planning &...

Learn More

Allosource Recognized as the Top Colorado Bioscience Manufacturer

AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products to help surgeons heal their patients, has been recognized as 2022 Bioscience Manufactu...

Learn More

Edgewise-Funded Natural History Trial Of Becker Muscular Dystrophy (BMD) Now Enrolling

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for the treatment of rare muscle disorders, t...

Learn More

CEO Antoinette Gawin will serve as Group Managing Executive Officer in Terumo Corporation’s New Executive Officers’ Management System

Terumo Blood and Cell Technologies, a medical technology company, announces the appointment of Antoinette Gawin to serve as Group Managing Executive Officer (GMEO) for Terumo Corporation (TSE:4543)....

Learn More

Terumo Blood and Cell Technologies Appoints Gene Stellon to Lead Innovation and Development

Terumo Blood and Cell Technologies, a medical technology company, recently appointed Gene Stellon as Senior Vice President, Innovation and Development (I&D). He will serve on the Executive Managem...

Learn More

Gilead Jumps Out Ahead of BMS in Second-Line B-Cell Lymphoma

Kite Pharma, a subsidiary of Gilead, announced that Yescarta (axicabtagene ciloleucel), a chimeric antigen receptor (CAR) T-cell therapy, has been approved by the U.S. Food and Dru...

Learn More

Weekly Policy Update: State Regulation of PFAS

The regulatory environment regarding the usage of perfluoroalkyl and polyfluoroalkyl chemicals (PFAS) in medical devices and other products is evolving to include potential action on the state level....

Learn More

GelSana Therapeutics Wins UNC Entrepreneurial Challenge

The University of Northern Colorado's Monfort College of Business has announced the winners of the 2022 Entrepreneurial Challenge. After making improvements to their business plans based on judges’ fe...

Learn More

Enveda Biosciences Adds Drug Development Leaders to Scale Efforts and Accelerate Progress

Enveda Biosciences, a leading biotechnology company harnessing nature’s chemistry to develop next-generation small molecule therapies, today announced the addition of three leaders to further scale an...

Learn More

Colorado's Women-founded Startups Make Huge Strides

CBSA member Inscipta is mentioned in Colorado's startups success. In a record year for venture capital in Colorado, firms founded by women saw sizable gains, too. Why it matters: The VC...

Learn More

U.S. FDA Clears Terumo Blood and Cell Technologies' New Plasma Collection Technology

The U.S. Food and Drug Administration (FDA) cleared the new plasma collection system developed by Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company. Rika is a next-generati...

Learn More

SmartTab Named as a Finalist at SXSW

CBSA Member SmartTab was named a Finalist in Health, Wearables, and Wellbring at SXSW. Congratualtions! SmartTabDenver, CO SmartTab is developing an advanced platform of ingestible capsules for oral d...

Learn More

Companies Bet You’re Ready to Test at Home for More Than Covid-19

The Covid-19 pandemic has hastened consumers’ willingness to test for more medical conditions at home, test makers said, expanding the market for self-diagnostic products. Manufacturers are devel...

Learn More

LightDeck Diagnostics and The Henry M. Jackson Foundation for the Advancement of Military Medicine receive $2M To Develop Rapid, Multiplexed Inflammation Test for Respiratory Illness

LightDeck Diagnostics, the company leveraging planar waveguide technology to deliver lab-quality diagnostics in minutes, today received a $2M contract from HJF, as funded by the Joint Program Exe...

Learn More

Colorado coalition a semifinalist for $100 million industry-building grant

The grant, if won, would allow for construction of bioscience and cleantech projects throughout the Denver, Boulder and Fort Collins areas — and the development of programs to improve the pipelines of...

Learn More

Statera Biopharma gets go-ahead for next phase of Crohn’s therapy trial

Statera Biopharma Inc. (Nasdaq: STAB) has received approval from the Central Institutional Review Board to move forward with the third phase of its clinical trial for STAT-201, its candidate for the t...

Learn More

Roy Smythe, M.D. and Scott Hutton Named to List of Top 25 Biotech CEOs of 2022

CBSA Members' CEOs are named to Top 25 Biotech CEOs list: SomaLogic's Roy Smythe, M.D., and Biodesix's Scott Hutton. The Healthcare Technology Report is pleased to announce The Top 25 Biotech CEOs of...

Learn More

EvoEndo Announces US FDA 510(k) Clearance for Single-Use Unsedated Transnasal Endoscopy (TNE) System

EvoEndo®, Inc. (“EvoEndo”), a medical device company developing systems for Unsedated Transnasal Endoscopy (TNE), has announced the receipt of 510(k) clearance from the U.S. Food and Drug Administrati...

Learn More

Evergreen Research Inc. is now ERI Group

ERI Group, formerly Evergreen Research, a leader in end-to-end medical product design and development, quality assurance, regulatory affairs and contract manufacturing services, unveiled its new name...

Learn More

Brickell Biotech Acquires Exclusive Global Rights to Portfolio of Novel STING Inhibitors Targeting Autoimmune and Inflammatory Diseases from Carna Biosciences

Brickell Biotech, Inc., a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of autoimmun...

Learn More

LightDeck Diagnostics and The Henry M. Jackson Foundation for the Advancement of Military Medicine receive $2M To Develop Rapid, Multiplexed Inflammation Test for Respiratory Illness

LightDeck Diagnostics, the company leveraging planar waveguide technology to deliver lab-quality diagnostics in minutes, today received a $2M contract from HJF, as funded by the Joint Program Executiv...

Learn More

Mining biotech opens Denver-area lab, plans quick expansion

A fivefold jump in demand for for certain metals that are key to manufacturing the wind power, solar energy, batteries and other systems needed in the clean energy transition is forecast by 2050. The...

Learn More

Colorado startups crush venture funding record in 2021 with $6.5B raised

In 2021, the state smashed previous venture funding records and closed the year with never-before-seen momentum. Find out more in the Denver Business Journal article.

Learn More

SomaLogic announces exclusive partnership with Illumina to develop sequencing-based proteomic solutions

SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a worldwide strategic collaboration with Illumina, a global next-generation sequencing technology leader. The m...

Learn More

AGC Biologics Appoints Whitney Sandberg as the new Vice President of Quality for its Colorado Facilities

AGC Biologics announced Whitney Sandberg has been appointed as the company’s Vice President for Quality in Colorado. In this position she will have executive oversight for quality operations at the co...

Learn More

Summit Biolabs Announces Changes to its Board of Directors

Summit Biolabs, a commercial-stage molecular diagnostics company harnessing the power of direct-to-PCR technology to transform the detection of infectious diseases, today announced the appointment of ...

Learn More

PharmaJet partner Zydus Cadila announces COVID-19 vaccine expansion plan to multiple countries with Korean firm

PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner Zydus Cadila, is partnering with Enzychem Lifesciences to manufacture their COVID-19 plasmid DNA...

Learn More

LivaNova holds ribbon-cutting for $10.5 million sterilization facility in Arvada

The Arvada manufacturing facility of LivaNova — a global medical device producer -unveiled a state-of-the-art $10.5 million sterilization facility on Dec. 15 that will allow the company to sterilize h...

Learn More

PharmStars Announces 2021 Accelerator Graduates, Includes CBSA Member SmartTab

12 digital health startups have successfully completed PharmStars’ inaugural 10-week pharma-focused accelerator program. PharmStars, the pharma-focused accelerator for digital health startups, is deli...

Learn More

Inscipta Named in Colorado's Top 10 Tech and Startup Fundings of 2021

There have been more than a dozen deals north of $100 million in 2021, including three over $200 million in the technology space. CBSA member and Boulder-based Inscripta Inc., a digital genome enginee...

Learn More

Colorado Coalition Selected as Finalist for Economic Development Administration’s (EDA) Build Back Better Regional Challenge

Colorado Coalition will Compete for up to $100 Million to Supercharge Economy through Eight Projects The Colorado Coalition, the regional stakeholder group led by Innosphere Ventures in part...

Learn More

PharmaJet partner, Nykode Therapeutics announces phase 1/2 clinical trial with next generation DNA-based COVID-19 vaccine candidates

Vaccines to be delivered via needle-free jet injection GOLDEN, Colo. — December 14, 2021 — PharmaJet®, the maker of innovative, needle-free injection technology, today announced that one of...

Learn More

Biodesix Partners with Spesana to Streamline Digital Access to Molecular Diagnostics for Precision Medicine in Lung Cancer

 Spesana, the developer of a novel electronic operating system to unify EMRs, and Biodesix Inc. (NSDQ: BDSX), a leading data-driven diagnostic solutions company with a focus in lung dis...

Learn More

Proov® to Expand Women’s Hormone Health Solutions to Advance Women’s Health and Offer More Accessible Care with $9.7M Series A Funding

Proov, creator of the first and only FDA-cleared PdG-testing kit to educate and empower women about their reproductive health, announces today it raised $9.7 million in Series A Funding. The round was...

Learn More

Genapsys Selects Colorado for Manufacturing and R&D Expansion, Brings 240 new jobs to Colorado

Colorado continues to emerge as a bioscience hub. Genapsys, a life science company, has announced plans to open a second location in Westminster bringing approximately 240 new jobs to Colorado.  Genap...

Learn More

SmartTab Launches StartEngine Equity Crowdfunding Campaign on a Mission to Revolutionize Drug Delivery

SmartTab has announced the launch of its crowdfunding campaign on StartEngine (https://www.startengine.com/smarttab). The digital health startup is opening up investments to the public to accelerate t...

Learn More

Vivaldi Biosciences Files PCT Patent Application for Universal Flu and Covid-19 Combination Vaccine

Vivaldi Biosciences, a clinical-stage biotechnology company developing nasal-spray vaccines for viral respiratory diseases, today announced it has filed an international patent application for its com...

Learn More

SolidAIRity Flex™ Launches First-in-Patient Limited Market Release

Securisyn Medical has formally launched its FDA-registered, Adult SolidAIRity Flex™ Endotracheal Tube Securement device, at Memorial Hospital - University of Colorado Health in Colorado Springs. This...

Learn More

Aspero Medical Awarded $1M Grant

Startup MedTech company improving endoscopy procedures with patented balloon technology continues to develop product line Aspero Medical, a medical device startup company focused on design and develop...

Learn More

CBSA Member SmartTab Receives Two Awards: 2021 Colorado Company to Watch and 2021 Patient's Choice Award

CBSA member SmartTab is honored with two awards: SmartTab has been selected as a top award winner for the 2021 Colorado Companies to Watch. This highly prestigious award is designated to the most, “in...

Learn More

PharmaJet , WHO and BMGF conduct Somalia Polio Vaccination Campaign

 PharmaJet® the maker of innovative, needle-free injection technology, today announced that its Tropis® intradermal needle-free injection system is being used in a campaign in Somalia d...

Learn More

PharmaJet Presents Needle-free delivery of COVID-19 Vaccines and Beyond at World Vaccine Congress - Europe

Superior immunogenicity expands vaccine development with Needle-free delivery PharmaJet®, the maker of innovative, needle-free injection technology, announced that their latest partnerships and resear...

Learn More

Weekly Policy Update: Prescription Drug Affordability Review Board Members Appointed

This week, Governor Polis announced the appointment of the inaugural five members of the Prescription Drug Affordability Review Board (PDAB). The PDAB was created through the legislature’s passage and...

Learn More

Gates Biomanufacturing Facility Announces Strategic Manufacturing Agreement with Cell Therapy Pioneer, Nkarta

The Gates Biomanufacturing Facility (GBF) today announced a continued strategic agreement with Nkarta, Inc. to manufacture clinical supply of therapeutic Natural Killer (NK) cells. As part of this col...

Learn More

Brickell Biotech Announces Positive Topline Results, Achieving Statistical Significance on all Primary and Secondary Endpoints, from Both U.S. Phase 3 Pivotal Clinical Studies of Sofpironium Bromide Gel, 15% in Primary Axillary Hyperhidrosis Patients

Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for...

Learn More

New fund expands its investments into the Mid-America Mountain Plains region focusing on B2B SaaS, Cleantech, and Medtech Startups

Innosphere Ventures announced the launch of its second venture capital fund, Innosphere Ventures Fund II (Fund II), that focuses on leading early-stage investments for companies who are driving innova...

Learn More

Inotiv, Inc. Announces Expansion of In Vivo Pharmacology Offering with Acquisition of Plato BioPharma, Inc.

Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, today...

Learn More

Live Fully, Inc awarded a $299,000 SBIR Grant to develop Breathe Away devices for Long Term Oxygen Therapy Patients so they can confidently go about their daily activities of living without worrying about running out of oxygen

Live Fully, Inc., a medical device design company is focused on improving the daily lives of lung disease patients through the development of products dedicated to improving outcomes and quality of li...

Learn More

Viridian raising $85M on new shares

Viridian Therapeutics Inc. (Nasdaq: VRDN) is selling 6.2 million common shares at $11 apiece and about 23,000 shares of series B preferred stock at $733.37 to raise $85 million to continue its develop...

Learn More

Clovis pays off notes, raises $40M+ in ATM offering

In an effort to clean up its balance sheet, cancer-drug manufacturer Clovis Oncology Inc. (NYSE: CLVS) has paid off $64.4 million in maturing convertible senior notes due in 2021 and raised more than...

Learn More

Accure Acne Inc.™ announces the appointment of Jeffrey O'Donnell, Sr. to the Board

Accure Acne, Inc. announced today that Jeffrey O'Donnell, Sr. has joined Accure Acne's Board of Directors. Along with Chairman and Founder Christopher Carlton and Founder Ed B...

Learn More

Sen. Michael Bennet reintroduces much needed bill to fight superbugs: PASTEUR Act

As the pandemic rages on, Colorado’s senator is working to prevent the next one. With all the marvels of modern medicine, could humans still die from a paper cut? For years we’ve taken the ability to...

Learn More

Pegasus Announces New Location in Denver, Colorado

Pegasus, a leading provider in comprehensive cleaning and decontamination services announced today that they have opened a new office in Denver, Colorado. The new location is 3190 S. Vaughn...

Learn More

Securisyn Medical Awarded a $1.95M SBIR Fast-Track Grant to Develop SolidAIRity Flex™ Pediatric and Neonatal Endotracheal Securement Devices for Improved Clinical Safety

Securisyn Medical LLC, a provider of novel breathing and smooth tube and catheter securement products dedicated to improving patient outcomes, today announced the award of a Fast-Track Small Business...

Learn More

Innosphere Ventures Fund leads investment into bioscience company, GelSana Therapeutics

Innosphere Ventures Fund (Fund), a venture capital fund leading early-stage investments, has announced its second seed-stage investment into GelSana Therapeutics (GelSana). GelSana will use...

Learn More

Colorado Life Sciences Community Members Recognized in Regulatory Affairs Professional Society Awards

The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, phar...

Learn More

Tech transfer key to products spun off from CU Boulder, federal labs research

A chance meeting on a Boulder-area trail could lead to a better understanding of particles suspended in the air that have major impacts on weather, climate and air quality. Find out more in the Daily...

Learn More

Innosphere to build new 7,500-square-foot lab space in Fort Collins

In order to keep Colorado companies from relocating out of state because they can’t find a lab, Innosphere is building a new one. Read more in the Denver Business Journal's article about the new life...

Learn More

KromaTiD Announces Launch of dGH SCREEN™ for Unbiased Whole Genome Analysis of Chromosomal Structural Rearrangements

KromaTiD is pleased to announce the launch of dGH Screen™, their new service for mapping the human genome in single cells.  dGH SCREEN™ is built upon KromaTiD’s proprietary directional Genomic Hy...

Learn More

Colorado Springs-area science teacher receives $2,000 STEM grant, intensive biotech training

A Pikes Peak-area science teacher recently received a STEM grant from the Air Force Academy after completing an intensive biotechnology training program that she said will help make classes more inter...

Learn More

LightDeck Diagnostics Strengthens Leadership Team to Spearhead Commercialization of Rapid, Point-of-Care Diagnostics

LightDeck Diagnostics today announced additions to its executive leadership team, naming Russ Peloquin as Chief Commercial Officer and Frank Gill as Chief Product Officer. The two will be joining newl...

Learn More

TriSalus enrolls first patient in pressure-enabled drug delivery trial for treating melanoma

TriSalus Life Sciences announced today that it enrolled the first patient in its clinical study of a treatment for metastatic uveal melanoma. The PERIO-01 clinical study evaluates SD-101, an inve...

Learn More

Boettcher Foundation Stories on Boettcher Investigators, COVID Fund

2021 Boettcher Investigators In late May we announced the names of six leading Colorado researchers who are the newest recipients of grant funding through the Webb-Waring Biomedical Research Awards Pr...

Learn More

Brickell Biotech Expands Leadership Team, Appointing Dr. Monica Luchi as Chief Medical Officer

Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription...

Learn More

Brickell Biotech Acquires Exclusive Rights to Phase 1-Ready DYRK1A Inhibitor Program and Novel Platform Targeting Autoimmune and Inflammatory Diseases

Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription...

Learn More

Cytocom, Inc. Announces Plan to Adopt New Corporate Name “Statera BioPharma, Inc.”

Cytocom, Inc. (Nasdaq: CBLI), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced plans to change its corpor...

Learn More

Heads Up Health Extends Seed Round to $2.25M Led by Innosphere Ventures

 Innosphere Ventures’ seed-stage venture capital fund has announced its second investment into Heads Up Health (Heads Up) which gives Heads Up the ability to close out their seed round at $2.25 millio...

Learn More

CSURF announces the departure of Todd Headley, VP of Technology Transfer

It is with mixed emotions that CSURF announces the departure of Todd Headley, Vice President of Technology Transfer.  Todd’s contributions and impact at CSURF and Colorado State University have b...

Learn More

SomaLogic Closes Business Combination and Will Begin Trading Under the Ticker “SLGC” on the Nasdaq Stock Exchange

SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it has completed its business combination with CM Life Sciences II, Inc. (Nasdaq: CMIIU), a special purpose acqu...

Learn More

Zalgen Awarded CEPI Contract to Provide Test Kits for Largest Ever Lassa Fever Study in West Africa

Zalgen Labs LLC (Zalgen), a biotechnology and diagnostics company focused on preparedness for high impact, neglected infectious diseases including Lassa Fever (LF), today announced its contract with t...

Learn More

PharmaJet Partner Zydus Cadila Announces Emergency Use Authorization Approval for World’s First Plasmid DNA COVID-19 Vaccine

Vaccine delivered exclusively with the PharmaJet Needle-free System GOLDEN, Colo.- PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner, Zydus Cadila...

Learn More

Golden-based BioIntelliSense ramps up with $45M in financing to scale vital-monitoring sticker

The Golden-based company received FDA approval and insurance reimbursement approval for a remote monitoring wearable that can continuously collect vital signs data from a patient. Find out more in the...

Learn More

Edgewise Receives U.S. FDA Fast Track Designation for EDG-5506 for the Treatment of Individuals with Becker Muscular Dystrophy (BMD)

Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for rare muscle disorders, today announced t...

Learn More

KromaTiD Appoints Nathan Wood as Chief Executive Officer

KromaTiD, Inc. announces that Nathan Wood, will be joining as its Chief Executive Officer. Wood is a seasoned executive with thirty years of experience in the life science industry and is the for...

Learn More

Fitzsimons Innovation Community Accelerates Growth

Breaks ground on first full-scale commercial manufacturing facility, for cell and gene therapy AURORA, Colo. (August 12, 2021) – Today, Fitzsimons Innovation Community breaks ground on its new bioscie...

Learn More

Terumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapy

Terumo Blood and Cell Technologies (Terumo), a medical device company specializing in a portfolio of technology, software and services for blood component collection, therapeutic apheresis and cellula...

Learn More

AGC Biologics Acquires Commercial Facility, Expanding Cell & Gene Therapy Global Service Offerings

AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the finalization of the purchase of a state-of-the-art commercial manufacturing...

Learn More

Boulder iQ Names Larry Blankenship as Director, Helping Life Sciences Companies with Product Development

Boulder iQ has named Larry Blankenship director. Blankenship is a veteran medical device industry professional, with more than 30 years of experience in product development, manufacturing, regulatory...

Learn More

CSU Receives $2 Million Grant to Help Prevent Future Pandemics

Building on its response to the COVID-19 pandemic, Colorado State University has received a $2 million commitment from The Anschutz Foundation to further the development of new solutions for building...

Learn More

Evergreen Research Appoints New President, Natasha Bond

Evergreen Research, Inc. (Evergreen), a leading provider of contract development, manufacturing, and regulatory/quality assurance services, is pleased to announce the appointment of Natasha (Tasha) Bo...

Learn More

Nasal-Spray Combined Vaccine for Covid and Flu Shows Protection

Vivaldi Biosciences, a clinical-stage biotechnology company developing genetically engineered intranasal vaccines for viral respiratorydiseases, today announced positive preclinical data supporting fu...

Learn More

Outlook Therapeutics Appoints C. Russell Trenary III as President and Chief Executive Officer

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, t...

Learn More

LightDeck Diagnostics Appoints Nick Traggis as CEO to Scale Company Operations Through Next Phase of Growth

 LightDeck Diagnostics today announced that Nick Traggis has transitioned from executive vice president of Corporate Development to Chief Executive Officer (CEO). Chris Myatt, who precedes M...

Learn More

TANOVEA® (rabacfosadine for injection) Receives Full FDA Approval as First Treatment for Lymphoma in Dogs; Elanco Acquires Product from VetDC, Inc

Elanco Animal Health Incorporated (NYSE: ELAN) announced that the  FDA has granted full approval of Tanovea for the treatment of lymphoma in dogs, making this the first conditionally approved new...

Learn More

FDA Grants First Full Approval for Treatment of Lymphoma in Dogs

Today, the U.S. Food and Drug Administration fully approved Tanovea (rabacfosadine injection) to treat lymphoma in dogs. Lymphoma, also called lymphosarcoma, is a type of cancer that can affect many s...

Learn More

Long-time CBSA Member Aerotek to Change Name

Aerotek, a leading talent solutions provider, today revealed that its three highly specialized business units—Industrial, Professional, and Engineering and Sciences—have separated into independen...

Learn More

ARCA Biopharma Provides Update On Aspen-COVID-19 Phase 2B Clinical Trial Evaluating RNAPC2 as a Potential Treatment for COVID-19

CBSA Member ARCA Biopharama is receiving approvals from regulators in Argentina and Brazil to test your possible COVID-19 treatment. Find out more in the press release.

Learn More

VitriVax Announces Series A Financing to Further Demonstrate Feasibility of its Thermostable, Single-Dose Vaccine Technology, Aiming to Make Life-Saving Biologics Widely Accessible to Underserved Populations Globally

VitriVax, developer of a novel stabilization and delivery platform for vaccines and therapeutics, today announced it has closed its first institutional financing round with Adjuvant Capital. Series A...

Learn More

DOD, HHS Awards a $35.1M contract to LightDeck Diagnostics to increase production of its 5-Minute point-of-care tests for COVID-19

On July 8, 2021, the Department of Defense (DOD), on behalf of and in coordination with the Department of Health and Human Services (HHS), awarded a $35.1 million contract to LightDeck Diagnostic...

Learn More

PharmaJet partner Zydus Cadila seeks EUA on world’s first plasmid DNA COVID-19 vaccine

PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner Zydus Cadila has applied for Emergency Use Authorization (EUA) to the office of the Drug Control...

Learn More

AGC Biologics Enters Agreement to Acquire Facility in Longmont, CO, Eyeing to Significantly Expand Their Cell and Gene Therapy Capabilities and Offerings

AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the signing of a purchase agreement for a state-of-the-art Cell and Gene Therapy...

Learn More

Vaporox Closes on a $4M Series A Fund Raising Round Led by Bioventus

Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has completed a minority investment in Vaporox, Inc., a developer of a highly innovative...

Learn More

At-home fertility test kit maker Proov expands to EU after landing CE clearance

At-home fertility test maker Proov is expanding its footprint to Europe after receiving CE marking for its ovulation-confirming test kit. Proov’s ovulation testing kit got clearance by the F...

Learn More

Brickell Biotech Announces Initiation of a Phase 1 Study of Sofpironium Bromide Gel in Primary Palmoplantar Hyperhidrosis Patients by its Development Partner, Kaken Pharmaceutical in Japan

Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatm...

Learn More

Inside Medtronic's plans for its new 400,000-square-foot Lafayette campus

The company is preparing to break ground on its new campus, which will prioritize collaboration and innovation. Find out more in the Denver Business Journal article.

Learn More

Enveda Biosciences Closes $51M Series A Financing Led by Lux Capital

Enveda Biosciences, a leading biotechnology company harnessing the power of nature’s chemistry to develop next-gen small molecule therapeutics, today announced an oversubscribed $51M Series A funding...

Learn More

The Top 25 Women Leaders in Consumer HealthTech of 2021, CBSA Congratulates Tasha Bond from member company Sana Health

The Healthcare Technology Report is pleased to announce the Top 25 Women Leaders in Consumer HealthTech of 2021. From developing new technologies and products for often overlooked areas of women’s hea...

Learn More

Lohocla Research to Present at 2021 BIO

Lohocla Research announced today that it has been selected to deliver a company presentation at 2021 BIO Digital, the premier biotech event. BIO Digital is scheduled June 10-11 & 14-18, 2021. Jim...

Learn More

EvoEndo Raises $10.1 Million to Make Unsedated Transnasal Endoscopy a Reality for Patients and Physicians

EvoEndo® Inc., (“EvoEndo” or “the Company”) a preclinical medical device company developing systems for unsedated Transnasal Endoscopy (TNE), announced it has secured $10.1M in equity financing....

Learn More

FDA grants accelerated approval for ADUHELM™ as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease

-- Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd. (Tokyo, Japan) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for ADUHELM™ (aducanumab-a...

Learn More

Foresight Diagnostics Completes Series A Financing to Accelerate Development of its Industry-Leading Minimal Residual Disease (MRD) Technology

Foresight Diagnostics today announced the close of its $12.5M Series A financing led by Civilization Ventures and Bluebird Ventures, with participation by Pear Ventures, to commercialize the...

Learn More

Flagship Biosciences Expands Tissue Image Analysis Capabilities at New Colorado Location in Support of Pharmaceutical and Clinical Clients

Flagship Biosciences, the leader in data-centric pathology and tissue analysis, today announced that the company has moved its headquarters to a new location in Broomfield, Colorado, just north of Den...

Learn More

FDA Approves LUMAKRAS™ (Sotorasib), The First And Only Targeted Treatment For Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved LUMAKRAS™ (sotorasib) for the treatment of adult patients with KRAS G12...

Learn More

Proov Announces New Patented Test Method for Assessing Ovarian Quality

– Proov, a science-based hormone testing company and the leader in testing urine for PdG to confirm ovulation, is announcing today that it has received patent issue notification for a utility patent c...

Learn More

SomaLogic launches the SomaSignal™ Proteomics for Precision Medicine Initiative with healthcare innovators: Emory University, Intermountain Healthcare, CommonSpirit Health and UCHealth

SomaLogic announced today its SomaSignal™ Proteomics for Precision Medicine Initiative, the first large-scale, clinically focused partnership effort aimed at equipping healthcare providers with the po...

Learn More

LightDeck Diagnostics Honored as Bronze Stevie® Award Winner in 2021 American Business Awards® for Its Lab-Quality, 5-Minute Diagnostics Platform

LightDeck Diagnostics was named the winner of a Bronze Stevie® Award in the Startup of the Year category in The 19th Annual American Business Awards® today. The company was recognized for it...

Learn More

KromaTiD receives $2M of growth investment from BroadOak Capital Partners

KromaTiD announced BroadOak Capital Partners made a $2M investment in the company. KromaTiD said its sales and operations are rapidly accelerating, driven by growing market adoption of their products...

Learn More

Cerapedics Announces FDA Breakthrough Device Designation Granted for P-15L Bone Graft for the Treatment of Degenerative Disc Disease

Cerapedics Inc., an ortho-biologics companydedicated to enhancing the science of bone repair, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device desi...

Learn More

The World's First Fully Automated Benchtop Digital Genome Engineering Platform Is Here

As synthetic biology continues to grow, advanced benchtop systems are becoming available to make research and product development easier. Now, Inscripta, a digital genome engineering company, has...

Learn More

Accure Acne, Inc(R) has Launched a Private Placement Offering on the M-Vest Platform to raise up to $20.0 Million

Accure Acne, Inc. ("Accure Acne" or the "Company") has launched a private placement offering on the M-Vest platform to raise up to $20.0 million. Accure has developed an energy-based device (the...

Learn More

CereHealth Corporation Names James Chomas, Ph.D., as New CEO

Dr. Chomas brings an added level of industry firepower to CereHealth's accelerated growth and capital investment plans for its innovative brands of medical technology. DENVER, April 20, 2021...

Learn More

Evergreen Research Hires Geoffrey Uhl as Director of Product Development

Evergreen Research, Inc. (Evergreen), leaders in medical device services, today announced Geoffrey (Geoff) Uhl has joined the company as the newest member of the Evergreen executive team. Geoff will o...

Learn More

Professor Larry Gold to Receive a Lifetime Achievement Award at Aptamers 2021

We are delighted that Professor Larry Gold will receive a Lifetime Achievement Award on behalf of the International Society on Aptamers (INSOAP) for his pioneering and extraordinary contributions to t...

Learn More

Cogent Biosciences Announces Creation of Cogent Research Team

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the formation of the Cogent Research Team l...

Learn More

Alan Greene Joins Securisyn Medical, LLC as Chief Marketing Officer

Securisyn Medical LLC, (“Securisyn” or the “Company”), is pleased to announce that Alan (Al) Greene has joined the Company as its Chief Marketing Officer, effective April 1st, 2021. Securisyn Medical,...

Learn More

TriSalus Life Sciences and MD Anderson Announce Strategic Research Collaboration to Evaluate Treatment of Solid Tumors

The University of Texas MD Anderson Cancer Center and TriSalus Life Sciences®, an emerging immuno-oncology company committed to transforming outcomes for patients with liver and pancreatic tumors, tod...

Learn More

Applied Spectral Imaging and KromaTiD Announce Strategic Commercial Partnership

Applied Spectral Imaging (ASI) and KromaTiD, Inc. announced today that they have entered into a strategic commercial partnership, granting ASI worldwide rights to market KromaTiD’s proprietary Pinpoin...

Learn More

Inscripta Announces the First Commercial Shipment of Its Onyx™ Digital Genome Engineering Platform and Closes $150 Million in New Financing

Inscripta, Inc., the digital genome engineering company, today announced the first commercial shipment of its Onyx™ platform and the closing of a $150 million Series E financing round led by Fide...

Learn More

CU Anschutz Schools and Colleges Rank Among Nation’s Best in 2022 U.S. News & World Report Listing

The University of Colorado School of Medicine has moved up in rankings for primary care and research; first time in top 30 for research. Colorado School of Public Health makes Top 20 best programs in...

Learn More

SomaLogic, Leading AI-Data Driven Proteomics Platform for Advanced Research and Clinical applications, to Combine with CM Life Sciences II, to Drive Growth and Expand Technology Platform

SomaLogic, a global leader in proteomics technology, powered by a proprietary platform, the largest clinical proteomic database and next generation artificial intelligence and machine learning, and CM...

Learn More

Edgewise Therapeutics Announces Pricing of Initial Public Offering

Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for rare muscle disorders, announced today t...

Learn More

Aytu BioScience Announces Close of Merger with Neos Therapeutics

Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, today announced the closing of its merger with N...

Learn More

Flagship Biosciences Announces Strategic Executive Team Additions

Flagship Biosciences, the leader in data-centric pathology and tissue analysis, today announced strategic additions to its executive team. Dr. Roberto Gianani, MD has been promoted to Chief Medical Of...

Learn More

Rare disease biotech Edgewise Therapeutics files for a $100 million IPO

Edgewise Therapeutics, a Phase 1 biotech developing small molecule therapies for rare muscle disorders, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Edgewise...

Learn More

Medtronic's plans for 42-acre campus in Lafayette approved by City Council

The approval marks a win for both the biotechnology giant as well as Colorado economic development leaders, who offered the company millions in tax credits in hopes of drawing new high-paying jobs. Le...

Learn More

RxRevu Launches SwiftMx - Healthcare's First and Only Complete Price Transparency Solution

RxRevu, the leading provider of prescription price transparency solutions, has announced the expansion of its services to include the delivery of medical benefit coverage and cost information to elect...

Learn More

CSU Vaccine Research Advances, Groundwork Begins to Develop Coronavirus Vaccine for the Next Pandemic

As scientists at Colorado State University continue their research on four coronavirus vaccine candidates, investigators are developing a plan to collaborate with scientists at other universities to c...

Learn More

Biodesix CEO Scott Hutton Selected as One of Top 25 Biotech CEOs of 2021

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that The Healthcare Technology Report announced Chief Executive Off...

Learn More

Gates Biomanufacturing Facility reaches protein biologic manufacturing milestone

The Gates Biomanufacturing Facility (GBF) has completed the manufacturing and release of a protein-based biologic under Good Manufacturing Practice for Phase 1 Investigational Drugs for first-in-human...

Learn More

LightDeck Diagnostics Gets $5.65 Million for Rapid, Portable SARS-CoV-2 Antigen Test

LightDeck Diagnostics was awarded a $5.65 million contract to develop a rapid antigen test to detect SARS-CoV-2. The funding, provided by the Biomedical Advanced Research and Development Authorit...

Learn More

Flagship Biosciences Announces Patent

Flagship Biosciences, the leader in data-centric pathology tissue analysis, today announced that the United States Patent and Trademark Office has issued Flagship a new patent, number 10,839,512 entit...

Learn More

Biodesix Partners with Chicago Public Schools for COVID-19 Testing to Safely Reopen Schools

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that the company has partnered with Chicago Public Schools (CP...

Learn More

Congratulations from Colorado Life Sciences Ecosystem to Richard C. Duke, Ph.D. Named 2020 Tibbetts Award Winner

Dr. Duke has made a career out of innovating, teaching, learning, and successfully commercializing technologies. His efforts have led to numerous policies benefitting innovation and business as well a...

Learn More

Invitae (formerly ArcherDX) Announces Pricing of Public Offering of Common Stock

Invitae Corporation (NYSE: NVTA) today announced the pricing of an underwritten public offering of 7,766,990 shares of its common stock at a price to the public of $51.50 per share. All of the shares...

Learn More

Editas Medicine Announces Pricing Of Offering Of Common Stock

Editas Medicine, Inc. (Nasdaq: EDIT), a leading gene editing company, today announced the pricing of an underwritten offering of 3,500,000 shares of its common stock at a public offering price of $66....

Learn More

Company Name Change to Viridian Therapeutics and New Executive Appointments, Including Expansion of Leadership Team

miRagen Therapeutics, Inc. (NASDAQ: MGEN), a development-stage biotechnology company, today announced its name change to Viridian Therapeutics, Inc. (“Viridian”). Beginning tomorrow, Viridian will tra...

Learn More

AGC Biologics Appoints David Stewart as the New General Manager/Site Head of the Boulder, Colorado Site

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced a new appointment to oversee the startup, strategic development and operatio...

Learn More

Colorado Researchers Received Almost Half a Billion Dollars in 2020 NIH Grants

The University of Colorado Denver and the Anschutz Medical Campus received the majority of health research grants, including $1.8 million for projects specific to Covid-19. Find out more in the Denver...

Learn More

SomaLogic Appoints Jason Cleveland, Ph.D. as Chief Technology Officer

SomaLogic Inc., a global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, today announced the appointment of Jason Cleveland, Ph.D. as the com...

Learn More

DU scientists develop breakthrough COVID-19 antibody test

The test is so accurate, it can determine whether a person's symptoms will be mild or severe. Scientists at the University of Denver's (DU) Knoebel Institute for Healthy Aging, in collaboration with t...

Learn More

Purdue partners with Colorado company to offer rapid testing for students ahead of spring 2021 semester

Purdue University is partnering with a Colorado company led by a Purdue alum to offer rapid antigen COVID-19 testing for undergraduate, graduate and professional students taking classes on the West La...

Learn More

SomaLogic Expands Its Commercial Capabilities with Three New Senior Leaders

SomaLogic Inc., a privately held health information company, announced today the appointments of Angela Bakker Lee, Ph.D. as executive vice president for healthcare markets, Tracy Hervey, MBA as execu...

Learn More

Bolder Surgical launches CoolSeal™ Vessel Sealing Platform

Bolder Surgical, today announced the launch of its CoolSeal™ Vessel Sealing platform.  Founded in 2010 as JustRight Surgical, Bolder Surgical provides surgeons right-sized surgical instruments to safe...

Learn More

Colorado Bioscience Companies Ramp Up Vaccine Development in 2021

Several Colorado companies are working on vaccines or technology to enhance vaccine distribution. Find out more in the Denver Business Journal article.

Learn More

SomaLogic Adds $81M to Series A Financing Totaling $214M

SomaLogic, Inc., global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, announced today that it added $81M to its current funding round with...

Learn More

Edgewise Therapeutics Completes $95 Million Series C Financing to Advance Clinical Development of Muscular Dystrophy Program

Edgewise Therapeutics, a clinical-stage biopharmaceutical company developing orally bioavailable, small molecule therapies for musculoskeletal diseases, today announced the closing of a $95 million Se...

Learn More

SomaLogic Closes $121M Series A Financing Led by Casdin Capital

SomaLogic, Inc., global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, announced today that the Company has successfully closed an Initial S...

Learn More

$7.7 Million Advanced Industries Awards Fuel 37 Colorado Start-ups

Colorado Office of Economic Development and International Trade (OEDIT)’s Advanced Industries Accelerator Grant Program realeased a list of 37 Colorado start-ups approved for funding. A total of...

Learn More

Prima-Temp Awarded Groundbreaking Patent Using Artificial Intelligence For Ovulation Prediction

Prima-Temp, Inc., a leader in developing digital health solutions through chronobiology, has been awarded a patent recognizing its innovative approach to applying artificial intelligence (AI) to women...

Learn More

Boulder-based biotech SomaLogic has entered a five-year partnership with the Food & Drug Administration

It can be very difficult to manufacture generic versions of biologic drugs. But SomaLogic has a test that can help determine whether a new drug candidate is similar enough to the original drug to be c...

Learn More

L7 Informatics Automates Lab Operations and Supports Washington University School of Medicine with Workflow for Its Saliva-based COVID-19 Test

L7 Informatics announced that it has deployed L7 | ESP to automate all lab operations starting with COVID-related workflow at the Genome Technology Access Center (GTAC@MGI) in the McDonnell Genome Ins...

Learn More

To Support Go/No-Go Decisions in Early Drug Development, Inotiv Got It Together — Fast

Pharmaceutical and medical device companies are always under pressure to improve research productivity. Increasingly, they rely on contract research organizations (CROs) for access to specific experti...

Learn More

LightDeck Diagnostics Raises $11 Million Series B to Offer Five-Minute Affordable COVID-19 Tests, Taking the ‘Point-of-Care’ Anywhere

LightDeck Diagnostics today announced $11 million in Series B financing from Incubic, Entrada and Boulder Ventures. The funds will support the development and commercialization of in vitro multiplex t...

Learn More

Boulder biotech Biodesix CEO: Why timing was right for IPO

In an exclusive interview, CEO Scott Hutton talks about the next steps for the company, which specializes in blood-based diagnostic tests for lung diseases. Find out more in the Denver Business Journa...

Learn More

Boulder biotech company Inscripta names new CEO

The company has been growing over the past several years, and recently went to market with its genomic engineering platform. Learn more in the Denver Business Journal article.

Learn More

MBio Diagnostics Announces Rebrand to LightDeck Diagnostics to Reflect Commitment to Its Innovative Waveguide Product Platform

MBio Diagnostics, the company taking the point-of-care anywhere with on-the-spot, central lab-quality diagnostics, announced today that it is changing its corporate name to LightDeck Diagnostics. The...

Learn More

Denver-Boulder among top U.S. life science clusters for the first time

The Denver metro area has ranked among the largest U.S. life science markets for the first time, in a new report from CBRE. The report on U.S. life sciences ranks the top clusters in the country. On t...

Learn More

Summit Biolabs Announces Strategic Collaboration to Develop and Commercialize Saliva Liquid-biopsy Tests for COVID-19 and Head & Neck Cancers

Summit Biolabs, Inc., an early-stage molecular diagnostics company specializing in saliva-based testing for COVID-19 and head & neck cancer, and the Colorado Center for Personalized Medicine (CCPM...

Learn More

PharmaJet’s Needle-free System to be used in Australian Clinical COVID-19 Trial

PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its Stratis® Needle-free Injection System will be used to deliver a vaccine against SARS-CoV-2 in a clinical...

Learn More

Invitae completes its $1.4B acquisition of Boulder-based ArcherDX

ArcherDX had previously applied for an IPO before the public company its acquisition was announced. Learn more in the Denver Business Journal.

Learn More

Brickell Biotech Announces Initiation of U.S. Phase 3 Program Evaluating Sofpironium Bromide Gel, 15% for the Treatment of Primary Axillary Hyperhidrosis

Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitati...

Learn More

Westminster biotech company shares new strategy for cancer treatments.

A Westminster biotech company has a new clinical development strategy following a recent acquisition it made. TriSalus Life Sciences is an emerging immuno-oncology company that has developed technolog...

Learn More

Aspero Medical Receives $310,000 Grant for Development of Pillar™ Micro-Textured Gastrointestinal Endoscopic Balloon Overtube

Gastrointestinal endoscopy focused startup company to expand development effort for novel endoscopic single balloon overtube product line. Aspero Medical, a medical device startup focused on developin...

Learn More

ARCA Biopharma files application for Covid-19 drug treatment

The company has a drug in its arsenal that it believes could be effective in the treatment of Covid-19 patients. Find out more in the Denver Business Journal.

Learn More

Ampio Reports Positive Results in Early Trial for IV Ampion treatment in COVID-19 Patients

Ampion-treated patients showed improvement from severe disease/hospitalization to uninfected/ambulatory on the ordinal scaleAmpion-treated patients showed greater improvement compared to patients trea...

Learn More

Proov Lands VC Funds as Demand Surges for its At Home Test Kits

Proov, an at-home hormone testing kit company, has announced funding from two venture capital firms that aim to build up underrepresented founders. The investment – the amount was not disclosed – from...

Learn More

Maker of Mask Designed to treat Chronic Pain Raises 5.8M

Hear from Richard Hanbury, Sana Health Founder, the story of how the company started and the drive behind it all. Hanbury has created a Lafayette-based company known as Sana Health, which produces med...

Learn More

AnGes and Brickell Biotech Announce a Collaboration Agreement for the Development of a Novel DNA Vaccine Candidate for COVID-19 in the U.S.

AnGes, Inc. (“AnGes”), announced today a collaboration agreement with Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company, through which Brickell has the right t...

Learn More

AveXis renamed Novartis Gene Therapies, signifying the growing importance of gene therapy to Novartis corporate strategy

AveXis is now known as Novartis Gene Therapies, marking another milestone in their journey to be the world’s leading gene therapy company. Novartis has renamed the previously acquired AveXis to Novart...

Learn More

EY Entrepreneur of the Year Finalist list for the Mountain Desert

CBSA sponsor, EY, released the EY Entrepreneur of the Year Finalist list for the Mountain Desert region today. Congratulations and amazing job to CBSA member DMC Biotechnologies, Inc. for being named...

Learn More

Bond Pet Foods Develops Lab-grown Meat Prototype, Plans for 2023 Commercialization

A Boulder food technology company is looking to change the way people think about pet food. Bond Pet Foods has developed a prototype for lab-grown pet food using real meat protein. While the startup i...

Learn More

CBSA Member Mentioned in Crisis Innovators

CBSA members PharmaJet and CirrusMD Inc. are featured in The Business Journals Crisis Innovators: How 8 Colorado Startups are Fighting COVID-19. Across the state, Colorado’s tech and startup innovator...

Learn More

Biodesix to Provide COVID-19 Testing for Colorado State University Campus

Biodesix, Inc., a leading diagnostic company with a focus in lung disease, today announced plans to provide COVID-19 ddPCR diagnostic testing for Colorado State University (CSU) as students return to...

Learn More

Terumo BCT Revamps Brand

Terumo BCT is revamping its brand to Terumo Blood and Cell Technologies to reflect the company promise to unlock the potential of blood and cells and its heritage to innovate with customers to serve m...

Learn More

Sana Health raises $5.8M to get through clinical trials

Sana Health Inc., is currently in the middle of its trials for the behavioral health device that uses a relaxation mask to relieve chronic pain and stress. Sana has raised $5.8 million in new venture...

Learn More

TriSalus Life Sciences Acquires Dynavax’s SD-101 Oncology Program in Purchase Agreement for up to $250 million in Milestone Payments plus Royalties on Future Net Sales

SD-101 is a proprietary investigational, second-generation, Toll-like receptor 9 (TLR9) agonist CpG-C class oligodeoxynucleotide. TriSalus plans to further develop SD-101 as an oncology therapeutic. F...

Learn More

Colorado-based New Iridium accelerating global production of potential COVID-19 treatment using light-driven chemistry

New Iridium, a company developing commercialized  photocatalysis technologies to accelerate drug development and manufacturing, has been awarded a National Science Foundation (NSF) Small Business Tech...

Learn More

KromaTiD Announces Launch of New Product, dGH In-Site™

KromaTiD, Inc. announced today the launch of its new product dGH In-Site™, a single-cell, high resolution, genome-wide DNA insert tracking assay. dGH In-Site™ enables researchers to directly measure t...

Learn More

Boulder Biotech Company to be Acquired for $1.4B

Just a few weeks ago, the company filed for an IPO. Now, it's being acquired. Find out more in the article from Denver Business Journal.

Learn More

Brickell Biotech, Inc. Announces Pricing of $20.1 Million Underwritten Public Offering

Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitati...

Learn More

Edgewise Therapeutics Appoints Kirsten L. Gruis, M.D., M.S. as Chief Medical Officer

Edgewise Therapeutics, a biopharmaceutical company developing small molecule therapies for musculoskeletal diseases, today announced the appointment of Kirsten L. Gruis, M.D., M.S. to the newly create...

Learn More

ArcherDX Enters Collaboration with Bristol Myers Squibb to Apply Personalized Cancer Monitoring (PCM™) to Clinical Research

ArcherDX, Inc. today announced it is entering into a collaboration with Bristol Myers Squibb (BMS) to utilize Personalized Cancer Monitoring (PCM™) assays to understand the potential benefits of minim...

Learn More

Cetya Therapeutics Announces Issuance of New Patents Covering its HDAC Inhibitor CT-102

Cetya Therapeutics, Inc. today announced issuance of US Patent No. 10,676,504 and Australian Patent No. 2016229324 covering CT-102, Cetya’s proprietary HDAC inhibitor. CT-102 has demonstrated excellen...

Learn More

Flagship Bioscienc